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Transport protein particle complex component 11 (TRAPPC11) is a subunit of TRAPP 
III, a protein complex which is involved in membrane traffic, autophagy and maintenance 
of Golgi structure. The mechanisms by which it functions in these processes are not fully 
understood. Mutations in human TRAPPC11 have been linked to a wide spectrum of 
phenotypes including developmental delays, muscular dystrophies, intellectual 
disabilities, dystroglycanopathies and fatty liver. Here, we show that TRAPPC11 has a 
role upstream of autophagosome formation in macroautophagy. This contrasts with other 
TRAPP III proteins that function earlier (TRAPPC8) or later (TRAPPC12) than 
TRAPPC11 in the pathway. Upon TRAPPC11 depletion, LC3-positive membranes fail to 
become sealed autophagosomes and are not cleared during starvation conditions. ATG2B 
and its binding partner WIPI4/WDR45 are thought to be TRAPPC11 interactors, and 
TRAPPC11 depletion phenocopies the one of either ATG2 or WIPI4, which act in 
isolation membrane expansion. In the absence of TRAPPC11, recruitment of both these 
proteins to membranes is defective and fibroblasts from an individual with an altered 
carboxy-terminus of TRAPPC11 failed to recruit ATG2B-WIPI4, suggesting that this 
interaction is physiologically relevant. We propose a model whereby the TRAPP III 
complex coordinates growth and expansion of the isolation membrane through multiple 
interactions. 
TRAPPC11 can also function independent of the complex in the formation of lipid-linked 
oligosaccharides in N-glycosylation, so further research is needed to tease apart the roles 
of TRAPPC11 independently and within the complex. Collectively, all these dysregulated 
functions could potentially explain the spectrum of phenotypes seen in individuals having 
variants of TRAPPC11. The region around the highly-conserved Gly980 appears to be 
critical for membrane trafficking and N-linked glycosylation, causing the muscular 
weakness phenotype, whereas the extreme carboxy-terminus seems to be involved in 
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Chapter 1: Introduction 
1.1 Autophagy 
 
Autophagy is a housekeeping process that ensures clearance of damaged cellular 
components, energy homeostasis by recycling the cytosolic organelles, and protection by 
removing intracellular pathogens. There are three types of autophagy called 
macroautophagy, microautophagy and chaperone-mediated autophagy, all leading to 
proteolytic degradation in the lysosome (Boya et al., 2013). Macroautophagy, henceforth 
referred to as “autophagy”, is conserved across Eukarya and is the most comprehensively 
studied and the best-characterized of the three types. During this process the cytoplasmic 
components are delivered for degradation to the lysosomes in double-membrane vesicles 
called autophagosomes whose biogenesis is tightly regulated by several Autophagy-
related proteins (ATG) and membrane trafficking components. Moreover, membrane 
trafficking machinery is responsible for supplying membranes, lipids and proteins for the 
formation of autophagosomes and their subsequent fusion with endolysosomal 
membranes. Although mammalian cells undergo autophagy at a basal level for cellular 
housekeeping, this process is upregulated under physiological stress conditions such as 
starvation.  
 
Autophagosomes are formed de novo from a double membrane structure called isolation 
membranes or phagophores, henceforth referred as isolation membranes, which will 
elongate and entrap the cytoplasmic material. Once formed, the autophagosomes can fuse 
with multivesicular endosomes forming amphisomes (Eskelinen, 2005) which 
subsequently fuse with the lysosomes, or alternately autophagosomes can fuse directly 
with lysosomes forming so-called autolysosomes (Figure 1.1). During fusion with the 
lysosomes, the inner membrane and the autophagic cargo are degraded by lysosomal 
hydrolases in the acidic environment (Boya et al., 2013). Formation of an autophagosome 
includes (i) nucleation which refers to all signals that lead to formation of the nascent 
isolation membrane, (ii) expansion which includes membrane modeling and trafficking 
events that lead to isolation membrane growth and cargo sequestration, and (iii) closure 
which includes the sealing of the isolation membrane and formation of the closed 
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autophagosome. The transport process of the autophagosomes on the microtubules and 
their eventual fusion with the endosomes and lysosomes are collectively referred to as 
autophagosome maturation (Figure 1.1).  
 
Figure 1.1 Overview of the autophagy pathway 
The initial nucleation stage begins with generation of the phagophore/isolation membrane 
from a specialized cup-shaped ER-associated structure called an omegasome. During the 
subsequent expansion stage, the isolation membrane elongates and entraps cytoplasmic 
components into a double membrane structure, which upon closure becomes an 
autophagosome. Maturation of the autophagosome occurs through multiple fusion events 
generating either amphisomes or autolysosomes. The sequestered cargo is degraded by 
lysosomal hydrolases in the acidic environment of the autolysosome, and the degradation 
products are released back into the cytoplasm through permeases to be reused by the cell 
as energy sources or building blocks for synthesis of new molecules. Reproduced from 
(Soreng et al., 2018). 
 
1.2 The Core Autophagy Machinery and its Regulation 
 
The autophagy-related (ATG) proteins involved at different steps in autophagy were 
identified in yeast genetic screens and are well conserved in mammals (Klionsky et al., 
2011; Levine and Klionsky, 2017; Tsukada and Ohsumi, 1993). Much effort was put into 
the discovery of these proteins and in defining the sequence of the events during 
autophagy. The core autophagic machinery is crucial for the nucleation of 
autophagosomes and includes the ATG1/unc-51-like kinase (ULK1) complex, the 
Vps34/class III phosphatidylinositol 3-kinase (PIK3C3) complex, the ATG12–ATG5–
ATG16 complex, and the multi-spanning transmembrane protein ATG9 (Mizushima et 
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al., 2011; Nakatogawa et al., 2009) (Figure 1.2). 
 
Figure 1.2 Overview of core autophagy machinery 
Stress conditions such as nutrient depletion trigger the activation of the ULK1 complex 
which then promotes nucleation of the isolation membrane by phosphorylating 
components of the PI3KC3 complex. The latter activates local phosphatidylinositol-3-
phosphate (PI(3)P) production at the omegasomes. PI(3)P triggers a chain reaction that 




In mammals, the ULK1 complex activity (Chan et al., 2009; Hara et al., 2008; Hosokawa 
et al., 2009; Lee and Tournier, 2011; Mercer et al., 2009) is regulated by energy sensing 
kinases such as the serine/threonine kinase mechanistic target of rapamycin (mTOR) and 
AMP-activated protein kinase (AMPK) (Kim et al., 2011; Neufeld, 2010). Thus under 
glucose starvation, AMPK promotes autophagy by directly activating ULK1 through 
phosphorylation, while under nutrient-rich conditions, mTOR activity prevents ULK1 
activation and disrupts the interaction between ULK1 and AMPK (Kim et al., 2011).  
 
Once activated, ULK1 will trigger the activation of PIK3C3 complex I which specifically 
phosphorylates phosphatidylinositol to generate PI(3)P. The latter represents a signal for 
recruitment of the PI(3)P effectors called WD-repeat protein interacting with 
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phosphoinositides (WIPIs) (discussed below) and zinc-finger FYVE domain-containing 
protein 1 (DFCP1) to the omegasome (Volinia et al., 1995). WIPI2 recruits the ATG12-
ATG5-ATG16L1 (Kuma et al., 2002) complex that triggers the conjugation of LC3 to 
phosphatidylethanolamine (PE) (Otomo et al., 2013), thus forming the membrane-bound, 
lipidated form of this protein referred to as LC3-II. The latter is used as a membrane 
scaffold in autophagosome formation (Johansen and Lamark, 2019). 
 
Another important player in autophagosome biogenesis is the multi-spanning membrane 
protein ATG9. This is the only membrane protein of the autophagic machinery, and 
despite the fact that its role is not yet fully understood, it is essential for autophagosome 
formation in both yeast and mammals. ATG9 localizes to highly mobile cytosolic 
vesicles called ATG9 vesicles, with each vesicle having around 30 ATG9 molecules 
(Yamamoto et al., 2012). In nutrient-rich conditions, ATG9 vesicles are trafficked from 
the trans-Golgi network (TGN) to peripheral ATG9 reservoirs and transiently localize to 
isolation membranes when autophagy is induced (Imai et al., 2016).  
 
In mammals, ATG9 is internalized from the plasma membrane in AP2-clathrin-coated 
vesicles and directed to recycling endosomes through interaction with Tre-2/Bub2/Cdc16 
domain family member 5 (TBC1D5) (Popovic and Dikic, 2014; Puri et al., 2013). 
Furthermore, ATG9 and ATG16 vesicles coalesce at recycling endosomes (Popovic and 
Dikic, 2014), and from there TBC1D14, through interaction with TRAPP III, regulates 
trafficking of the ATG9 pool from recycling endosomes to the early Golgi, maintaining a 
cycling pool of ATG9 for initiation of autophagy (Lamb et al., 2016). Whether ATG9 
vesicles are incorporated into the isolation membrane remains unclear, although one 
study using advanced microscopy techniques showed that ATG9 vesicles interact 
transiently with the isolation membrane (Orsi et al., 2012). Another study reported that 
ATG9 vesicles are loaded with molecules used for autophagosome biogenesis (Shatz and 
Elazar, 2019). Delivery of specific proteins through ATG9 vesicles promotes omegasome 
formation, isolation membrane nucleation and completion of autophagosome formation. 
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1.3 Autophagosome Biogenesis 
 
Autophagosome biogenesis and maturation relies on membrane input from several 
endomembrane compartments (Wei et al., 2018) as well as on numerous membrane 
trafficking components such as coat proteins (Axe et al., 2008), SNAREs (Nair et al., 
2011), tethering factors (Davis et al., 2017) and RAB proteins (Szatmari and Sass, 2014).  
 
Autophagy begins with the formation of the isolation membrane and expansion through 
acquisition of lipids, which will eventually seal and form autophagosomes. The origin 
and identity of the isolation membrane was the subject of debate for decades, but now it 
is commonly accepted that isolation membranes are formed de novo on pre-existing 
membranes (Tooze, 2013). Isolation membrane biogenesis in mammalian cells differs 
from yeast in that there is not a single PAS, but rather several sites mainly formed from 
PI(3)P-enriched ER structures called omegasomes (Axe et al., 2008) that seem to have 
multiple curvature sensor molecules (Fan et al., 2011; Takahashi et al., 2007). However, 
despite this difference, the mechanism of isolation membrane biogenesis is highly 
conserved between yeast and mammals (Figure 1.2).  
 
Although the nucleation step can occur independently of PI3K activity (Itakura and 
Mizushima, 2010) the production of PI(3)P is essential for the stability of the membranes 
and for isolation membrane growth (Karanasios et al., 2013; Koyama-Honda et al., 
2013). PI(3)P has the shape of an inverted cone, with the planar surface extruding 
outwards from the membrane, forming a platform for incoming proteins to bind. 
Autophagy-specific PI3K complex binds membranes using amphipathic helices and 
stabilize the isolation membrane upon binding (Fan et al., 2011; Osawa et al., 2019a). 
PI3KC3 and ULK complexes are recruited to the omegasome and act in a synergistic 
manner to stimulate PI(3)P production and facilitate the elongation and increased 
curvature of the isolation membrane. PI(3)P production and WIPI2 recruitment trigger 
the addition of the ATG12–ATG5–ATG16L1 complex, which facilitates the transfer of 
LC3 to the isolation membrane.  
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The supply of biomaterials required for construction of a new isolation membrane comes 
from different intracellular compartments including ER-exit sites (ERES), Golgi, 
mitochondria, recycling endosomes and the plasma membrane (Hailey et al., 2010; 
Hamasaki et al., 2013a; Moreau et al., 2011; Puri et al., 2013; Ravikumar et al., 2010a; 
Ravikumar et al., 2010b). 
 
1.3.1 Expansion of the Isolation Membrane  
 
Following nucleation, the isolation membrane needs to expand in order to form a closed 
autophagosome. Yeast has been the prime model system for elongation studies, due to its 
relative experimental simplicity and its initial exploitation to identify the Atg machinery. 
In mammals, the process is still not fully understood, but it is known that elongation 
involves adding membrane lipids from different sources, along with the action of LC3 
and ATG12 with their conjugation systems (Hamasaki et al., 2013b; Kabeya et al., 2000; 
Kabeya et al., 2004; Mizushima et al., 2001). More recent work identified ATG2 as 
another important player in recruiting and binding lipids (see below).  
 
LC3 family members are involved in isolation membrane growth and autophagosome 
formation. Conditions that compromise lipidation of LC3 can influence the formation of 
autophagosomes (Kishi-Itakura et al., 2014; Komatsu et al., 2005; Sou et al., 2008) but do 
not affect nucleation or formation of the isolation membrane. Moreover, the amount of 
LC3 correlates with the size of the autophagosomes without affecting their number (Xie 
et al., 2008). How this peculiar ubiquitin-like protein promotes elongation and closure of 
the isolation membrane is not clear, however one model argues that LC3 participates in 
the tethering of small vesicles and promotes hemifusion of liposomes to the growing 
isolation membrane (Nakatogawa et al., 2007). The balance between 
conjugation/deconjugation systems (ATG12-ATG5 conjugation system and ATG4 
deconjugation) plays an important role in lipidation of LC3 and ultimately in the 




1.3.2.1 Role of ATG2 in Isolation Membrane Expansion 
 
Recent structural and biochemical analyses of autophagosome biogenesis have identified 
a new multifunctional protein, ATG2, that is able to tether membranes and incorporate 
lipids. In mammals ATG2 has two homologs, ATG2A and ATG2B, with redundant 
function in autophagosome and lipid droplet formation (Velikkakath et al., 2012). 
Simultaneous depletion of ATG2A and ATG2B produces a block in autophagic flux due 
to an accumulation of unsealed isolation membranes and clustering of enlarged lipid 
droplets (Velikkakath et al., 2012). Structural analysis of ATG2 reveals the existence of 
an amino-terminal membrane binding region with a role in autophagosome formation and 
in lipid transport (Osawa et al., 2019b; Valverde et al., 2019), an amphipathic helix 
(residues 1750-1767) with a role in ATG2 localization to lipid droplets and isolation 
membranes (Tamura et al., 2017), and a carboxy-terminal region (residues 1830–1938) 
with a role in localizing ATG2 to lipid droplets (Tamura et al., 2017).  
 
The amino-terminal membrane binding region of ATG2A has high similarity with 
VPS13, a protein known to be involved in lipid transport between organelles at 
membrane contact sites (Kumar et al., 2018). Moreover, ATG2 and VPS13 both seem to 
localize to autophagosome-ER contact sites and also share a cup-shaped region 
containing hydrophobic residues suitable for solubilizing lipids and transporting them 
between membranes (Kumar et al., 2018; Valverde et al., 2019). The key piece of 
evidence for their common functions was the ability of the amino-terminal membrane 
binding domain of ATG2A to rescue the phenotype of a simultaneous depletion of 
ATG2A and ATG2B (Valverde et al., 2019). This unexpected finding raised the question 
of how ATG2 is able to tether membranes, since the fragment used for rescue was too 
small to allow tethering. Although the small fragment is able to transport lipids, the full-
length ATG2 likely displays enhanced lipid transport due to existence of two binding 
domains that cooperatively are used to tether and to transfer phospholipids between 
different membranes (Chowdhury et al., 2018; Otomo et al., 2018; Valverde et al., 2019). 
Another suggestion came from the ability of ATG2A to form a complex with the PI(3)P 
effector WIPI4 (also called WDR45). WIPI4 binds to one of the tips of ATG2A, allowing 
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the complex to tether a PI(3)P-containing vesicle to another PI(3)P-free vesicle 
(Chowdhury et al., 2018; Otomo et al., 2018).  
 
The ATG2-WIPI4 interaction is also conserved in yeast, where Atg2 interacts with 
Atg18, the yeast homologue of WIPI4, and works with Atg9 in the elongation of isolation 
membranes (Kotani et al., 2018). Although in vitro WIPI4 is able to bind PI(3)P in the 
isolation membrane without assistance (Rieter et al., 2013), in vivo it seems that for 
efficient binding it requires the presence of the amphipathic helix of ATG2 (Kotani et al., 
2018). Recent work proposed that ATG2 interacts with GABARAP, an ortholog of LC3, 
with a role in isolation membrane elongation and localization to lipid droplets (Mihaela 
Bozic, 2019). However, while the ATG2A-WIPI4 interaction is dispensable for 
autophagosome biogenesis, the ATG2A-GABARAP interaction is essential. Thus, it was 
proposed that a combination of the LC3-Interacting Region domain and the amphipathic 
helix are responsible for proper localization of ATG2 to the isolation membrane and 
successful lipid transfer.  
 
To create an isolation membrane of 1µm, the average size of an autophagosome, the 
membrane requires about 25 million lipid molecules. Mammalian cells can form up to 
hundreds of autophagosomes in a very short amount of time (Maeda et al., 2019). Using 
comparative studies with a well characterized lipid transport module that accommodates 
two lipids it was shown that ATG2 is able to transfer about 20 lipid molecules at once 
(Valverde et al., 2019). However the rate of lipid transfer is too slow to explain the ability 
of the cell to form so many autophagosomes in such a short period. Since ATG2 is 
currently the only lipid transfer protein involved in elongation of the isolation membrane, 
elucidation of its role in autophagosome formation and its ability to tether membranes is 
essential for understanding the autophagosome biogenesis. 
 
1.3.2.2 Role of WIPI Proteins 
 
Another important component for isolation membrane nucleation and extension is the 
recruitment of the WIPI proteins (Proikas-Cezanne et al., 2015) that bind the 
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phosphoinositide lipids (Michell et al., 2006; Proikas-Cezanne et al., 2015) (Figure 1.2). 
WIPIs are part of a larger family of PI(3)P-interacting proteins called β-propellers that 
bind phosphoinositides (PROPPINs) (Thumm et al., 2013). In humans there are four 
members (WIPI1 - WIPI4) each with splicing variants (Proikas-Cezanne et al., 2004). By 
using homology modeling with WIPI1, it was proposed that WIPI proteins have seven 
WD repeats folded into a seven-bladed β-propeller (Proikas-Cezanne et al., 2004). 
 
Except for WIPI3 (also known as WDR45L) whose function remains obscure, the 
functions of the other WIPI proteins in autophagy are clearer. Treatments that induce 
autophagy cause the relocation of cytoplasmic WIPI1 to ATG12-ATG16L-LC3 positive 
membranes while treatments that block the formation of PI(3)P prevent the formation of 
the autophagosomes and relocation of the cytoplasmic WIPI1 (Gaugel et al., 2012; 
Proikas-Cezanne et al., 2004). The PI(3)P effector function of WIPI1 depends on the 
ULK1-dependent activation of PI3K3C and production of PI(3)P (Pfisterer et al., 2011). 
 
WIPI2 functions similarly to WIPI1 (Mauthe et al., 2011). It was found that WIPI2 
recruits the ATG12–ATG5–ATG16L complex and affects LC3 lipidation. WIPI2 was 
also linked to retrieval of ATG9 vesicles from the omegasomes, since the depletion of 
WIPI2 was followed by an accumulation of ATG9 vesicles in these structures (Orsi et al., 
2012). In selective autophagy WIPI2 was also found to interact with Tectonin beta-
propeller repeat containing 1 (TECPR1), a protein known to be involved in the fusion 
between autophagosome and lysosome (Chen et al., 2012; Ogawa et al., 2011). 
 
Upon starvation, WIPI4 (also known as WDR45) relocates from the cytosol to LC3-
positive structures (Lu et al., 2011). WIPI4 was implicated in omegasome maturation and 
autophagosome formation due to the observation that WIPI4-depleted cells have an 
accumulation of unsealed autophagosomes (Lu et al., 2011). WIPI4 homologues in yeast 
(Zheng et al., 2017) and C. elegans (Lu et al., 2011) were found to interact with Atg2 and 
to act downstream of LC3 in the formation of autophagosomes. Moreover, in humans 
ATG2 was found to act at the same hierarchical level, with WIPI1 being involved in the 
completion of autophagosome formation (Itakura and Mizushima, 2010; Velikkakath et 
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al., 2012).  
 
1.3.2 Autophagosome Completion and Maturation 
 
The mechanism of autophagosome closure is far from being understood, however it is 
clear that one condition for sealing is achieving the proper length of the isolation 
membrane (Kishi-Itakura et al., 2014). Even though multiple factors were linked to 
autophagosome closure, some of them have a role in isolation membrane formation 
and/or elongation, and therefore the effect on autophagosome closure is not specific to 
this step and might be indirect (Wen and Klionsky, 2016). Thus, factors that interfere 
with the lipidation of LC3, such as overexpression of an inactive form of ATG4 (Fujita et 
al., 2008) or depletion of ATG3 (Sou et al., 2008), or disturbance of ATG9 trafficking 
(Corcelle-Termeau et al., 2016), act in the elongation of the isolation membrane and have 
an indirect effect on autophagosome sealing. Recently it was proposed that 
autophagosome closure occurs through membrane scission, and since the endosomal 
sorting complex required for transport (ESCRT) is part of membrane-scission machinery 
(Knorr et al., 2015), it is tempting to speculate that this complex plays a role in 
autophagosome sealing (Christ et al., 2017). As a result of scission, the elongated 
isolation membrane will be converted from a cup-shape to a spherical autophagosome. 
The unsealed autophagosome can still fuse with the lysosomes, however the process is 
not efficient (Takahashi et al., 2018; Tsuboyama et al., 2016).  
 
After closure, autophagosomes undergo maturation through a series of fusion events with 
endocytic vesicles and lysosomes, forming autolysosomes where the autophagic cargoes 
are degraded by proteolytic hydrolases. Although the mechanism involved in lysosome-
autophagosome fusion is still unclear, this process must be tightly regulated in order to 
prevent nonspecific fusion events and ensure the specificity of cargo degradation. In 
mammalian cells many of the ATG proteins dissociate from the isolation membrane 
before closure suggesting that their removal is important for autophagosome closure and 
maturation (Koyama-Honda et al., 2013). Since some of the ATGs bind to isolation 
membranes through interactions with PI(3)P while others bind through their LC3 
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interacting domain, the removal of PI(3)P and LC3 following the closure of the isolation 
membrane destabilizes some ATGs (Kraft and Martens, 2012; Lamb et al., 2013; 
Mizushima et al., 2011). This destabilization enables ATGs dissociation and recycling. 
 
After closure and maturation, autophagosomes fuse with lysosomes for cargo 
degradation. Prior to fusion, the autophagosomes and lysosomes must come into 
proximity, tether, and then fuse in a SNARE-dependent manner. Spatial positioning of 
the autophagosomes and lysosomes is the first requirement for the fusion. During 
starvation the lysosomes cluster in the perinuclear region, due to intracellular pH changes 
(Heuser, 1989), whereas the autophagosomes formed initially in the peripheral region of 
the cell are transported along the microtubules to the same region in which the lysosomes 
are located (Fass et al., 2006) (Jahreiss et al., 2008). Similar to membrane fusion, the 
consumption of autophagosomes through their fusion with lysosomes requires a tethering 
factor (referred to as HOPS), RAB7, a trans-SNARE complex and different adaptors that 
link the autophagosomes and lysosomes to the core tethering machinery (Kriegenburg et 
al., 2018). The autophagosome-lysosome fusion mechanism is still under investigation. 
Many factors including cholesterol level (Punnonen et al., 1989), glycosylation (Guo et 
al., 2014), and autophagic lysosome reformation (Yu et al., 2010) seem to influence this 
mechanism. 
 
Given the requirement for similar non-ATG proteins in autophagosome biosynthesis and 
fusion and membrane trafficking, it is not unexpected that there is an interplay between 
these cellular processes regulated by the metabolic conditions of the cells (Staiano and 
Zappa, 2019). Thus, COPII machinery which is involved in anterograde trafficking, is 
redirected to autophagosome formation during starvation (Davis et al., 2016). 
Mammalian TRAPP III, also known to function in membrane trafficking, is involved in 
maintaining the ATG9 pool required for autophagy upon nutrient deprivation (Lamb et 
al., 2016; Longatti et al., 2012). The extent of the cross-talk between autophagy and 
membrane traffic remains to be determined and uncovering the roles of these 
“multitasking” proteins will give us a better understanding of the mechanisms underlying 
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autophagosome formation and consumption and perhaps give us tools to treat different 
diseases (Panda et al., 2019). 
 
1.4 Membrane Trafficking  
 
Intracellular vesicle trafficking is a process required for proper targeting of proteins and 
lipids within the endomembrane system. It occurs in virtually all cells and is important 
for maintaining cellular homeostasis, signal transduction, and intracellular compartment 
identity (Antonescu et al., 2014; Goh and Sorkin, 2013; Irannejad and von Zastrow, 
2014; Mellman and Yarden, 2013). Conceptually, vesicular trafficking can be reduced to 
four common steps: vesicle budding, transport, tethering, and fusion (Bonifacino and 
Lippincott-Schwartz, 2003). Each of these steps is tightly regulated to ensure that the 
vesicle formed from the donor membrane will fuse with the appropriate target membrane 
in a spatiotemporal manner. 
  
Vesicle budding represents selective incorporation of the cargo molecules into emerging 
vesicles derived from donor membranes with the help of specific coat and adaptor 
proteins such as clathrin, coat protein complex I (COPI) and coat protein complex II 
(COPII) (Kirchhausen, 2000). Each of these types of vesicles derives from specific 
cellular locations (Kreis et al., 1995; Sanderfoot and Raikhel, 1999) with clathrin-coated 
vesicles derived from the plasma membrane and TGN and fusing with endosomes or 
lysosomes (Loerke et al., 2009), COPI coated vesicles functioning in Golgi-to-ER and 
intra-Golgi retrograde traffic (Beck et al., 2009; Reinhard et al., 2003) and COPII coated 
vesicles functioning in anterograde traffic from the ER to Golgi (Barlowe et al., 1994; 
Malkus et al., 2002). Despite their different compositions, these coat protein complexes 
have two common functions: shaping the membranes into spherical vesicles and 
populating the vesicles with specific cargoes (Gomez-Navarro and Miller, 2016). 
 
Once formed, the vesicles will be transported towards their target or acceptor membrane 
where the specific cargo will be delivered (Klann et al., 2012). Tethering is crucial for the 
initial recognition of the vesicle by the target membrane (Li and Yu, 2014; Ohya et al., 
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2009; Starai et al., 2008). There are two types of tethering factors: coiled-coil tethers 
(Brocker et al., 2010; Witkos and Lowe, 2015), and multi-subunit tethering complexes 
(Brocker et al., 2010). The latter can be further subdivided into those that bind to 
SNAREs and act as RAB effectors (Meiringer et al., 2011), (Willett et al., 2013), 
(Dubuke et al., 2015), and those that function as guanine nucleotide exchange factors 
(GEFs) for RAB proteins including Transport Protein Particle complexes (Jones et al., 
2000; Wang et al., 2000) (see below). 
 
After recognition, the membranes fuse and the cargo is delivered into its destination 
(Bonifacino and Glick, 2004). Important players in this step are the soluble N-
ethylmaleimide-sensitive factor activating protein receptor (SNARE) proteins (Chen and 
Scheller, 2001). They are distributed in distinct subcellular compartments and mediate 
specific fusion events by specific pairing that drives the formation of a SNARE-pin 
structure, pulling the two membranes tightly together for fusion (Nichols et al., 1997; 
Sutton et al., 1998).  
 
RAB guanosine triphosphatases (RAB GTPases) are master regulators of all steps of 
membrane traffic (Hutagalung and Novick, 2011). They continuously cycle between an 
active form (GTP-bound) and an inactive form (GDP-bound) (Pereira-Leal and Seabra, 
2000). The intrinsic exchange between GDP and GTP is mediated by guanine nucleotide 
exchange factors (GEFs) while the GTPase activating proteins (GAPs) turn RAB 
GTPases off by stimulating their ability to hydrolyze GTP into GDP (Ross and Wilkie, 
2000). The crosstalk between RABs and their effectors ensures specificity and 
spatiotemporal regulation of vesicle traffic (Deneka et al., 2003). 
 
1.4.1 TRAPP Complexes 
 
One well-studied multisubunit tethering factor is the TRAPP family of complexes, first 
identified in yeast as a highly-conserved complex that localizes to the Golgi and 
functions in ER-to-Golgi transport upstream of SNAREs (Rossi et al., 1995; Sacher et al., 
2000; Sacher et al., 1998). It was later revealed that there were at least two TRAPP 
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complexes: a smaller one known as TRAPP III containing the so-called core of six 
subunits, along with the additional TRAPP III-specific protein Trs85 (Lynch-Day et al., 
2010), and a larger one called TRAPP II that contains the core with Trs65, Trs120, and 
Trs130 (Sacher et al., 2001). The core of the yeast TRAPP complexes was shown to bind 
and function as a GEF for the small GTPase Ypt1p in its nucleotide-free state converting 
it to its active form (Cai et al., 2008; Kim et al., 2006). Subsequent studies suggested that 
the size of the complex provides specificity such that TRAPP II binds and activates 
Ypt31/32 (Thomas and Fromme, 2016) and TRAPP III binds and activates Ypt1 (Thomas 
et al., 2018). 
 
All of the yeast subunits are conserved in higher eukaryotes including humans. Similar to 
yeast, there are two human TRAPP complexes that contain a core of proteins comprised 
of TRAPPC1, TRAPPC2, two copies of TRAPPC3, TRAPPC4, TRAPPC5 and 
TRAPPC6. In addition to this core, TRAPP II also contains TRAPPC9 and TRAPPC10, 
while TRAPP III contains the core with TRAPPC8, TRAPPC11, TRAPPC12 and 
TRAPPC13 (Sacher et al., 2000; Sacher et al., 1998; Scrivens et al., 2011) (Figure 1.3). 
The GEF activity of human TRAPP complexes is incompletely understood. However, it 
has been suggested that TRAPP II has GEF activity towards the human homologue of 
Ypt1 called RAB1, and for RAB18 (Li et al., 2017; Yamasaki et al., 2009) while the GEF 
activity of human TRAPP III has yet to be discovered. 
 
 
Figure 1.3 Cartoon depicting the stoichiometry and interactions between subunits in 
mammalian TRAPP complexes. 
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The core of proteins found in the complexes is colored in green, with the specific 
subunits colored blue for TRAPP II and grey for TRAPP III. The arrangement of the 
subunits in the core is based on biochemical and single-particle electron microscopic 
data. TRAPP II possesses two specific subunits (TRAPPC10 and TRAPPC9) while 
TRAPP III contains TRAPPC11, TRAPPC12 and TRAPPC13. Reproduced from (Sacher 
et al., 2019). 
 
1.4.2 TRAPP III 
 
Although TRAPP complexes are evolutionarily conserved, there are some structural 
differences between the mammalian and yeast TRAPP III complexes. Human TRAPP III 
has two additional subunits called TRAPPC2L and TRAPPC13 (Bassik et al., 2013; 
Scrivens et al., 2011) for which the yeast homologues are found in TRAPP II, and two 
additional subunits called TRAPPC11 and TRAPPC12 are found in the complex for 
which no yeast homologues have been identified (Scrivens et al., 2011).  
 
The specific subunits of human TRAPP III were linked to various functions in the cell. 
For example, the essential TRAPPC8 protein functions in autophagy (Behrends et al., 
2010), and has been implicated in vesicular transport in the cilia (Schou et al., 2014). The 
latter role was suggested based on the existence of the ASPM, SPD-2, Hydin (ASH) 
domains close to the carboxy-terminus known as targeting domains to the centrosome 
and cilia (Schou et al., 2014). Within the TRAPP III complex three subunits have ASH 
domains (TRAPPC8, TRAPPC11 and TRAPPC13), however localization to the 
centrosome has been demonstrated just for TRAPPC8 (Schou et al., 2014)(Figure 1.4). 
Besides ASH domains, TRAPPC8 has a α-solenoid domain bearing stretches of multiple 
tetratricopeptide repeats (TPR) close to the amino-terminus known as interaction modules 
and multiprotein complex mediators (Zeytuni and Zarivach, 2012). Interestingly, these 
TPR repeats are also found in TRAPPC11 and TRAPPC12 (Schou et al., 2014). Whether 
either of these two proteins has any role in cilia formation through its ASH domains or 




Figure 1.4 Representation of Tetratricopeptide Repeats (TPR) and ASPM, SPD-2, 
Hydin (ASH) domains 
Note the similarity between TRAPPC8 and TRAPPC11 comprising the TPR domains 
(shown as one region in blue) in the amino-terminus region and two ASH domains (in 
green) in the carboxy-terminus region. TRAPPC13 has just two ASH domains. 
Reproduced from (Schou et al., 2014). 
 
TRAPPC11 has a highly conserved 258 residue-long domain called foie gras (residues 
263-521) (Scrivens et al., 2011) which seems to have a critical role for the protein 
functions since deletions in this region lead to unstable protein (Bogershausen et al., 
2013). As part of TRAPP III (Scrivens et al., 2011), together with TRAPPC8 and 
TRAPPC12, TRAPPC11 immunoprecipitated with components of COPII (Bassik et al., 
2013; (Zhao et al., 2017), suggesting that TRAPP III is interacting with the COPII vesicle 
coat. In mammalian cells, depletion of TRAPPC11 led to TRAPP complex disassembly, 
Golgi fragmentation and early trafficking defects (Scrivens et al., 2011). While 
TRAPPC11 may also affect autophagy, the mechanism of any such role remains unclear 
(Behrends et al., 2010). TRAPPC11 can also function independently of the TRAPP 
complex in the synthesis of dolichol, the molecule required for assembly of the 
carbohydrate precursor in N-linked glycosylation of proteins (DeRossi et al., 2016). 
 
Originally identified in a proteomic study of the human autophagy network (Behrends et 
al., 2010) and assigned as a TRAPP III subunit (Bassik et al., 2013; Scrivens et al., 2011), 
TRAPPC12 can also function independently of the complex with a role in mitosis by 
regulating chromosome congression and kinetochore stability (Milev et al., 2015).  
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A recent study suggested that TRAPPC13 is important for the retrograde trafficking 
function of TRAPP III. Thus, depletion of TRAPPC13 led to a sensitization of cells to the 
Golgi-disrupting agent Brefeldin-A, limiting the ability of cells to respond to Golgi stress 
(Ramirez-Peinado et al., 2017). 
 
1.4.3 TRAPP III and Diseases 
 
Due to the presence of more than one TRAPP complex, and perhaps due to 
multifunctional proteins, mutations in human TRAPP complex subunits have been 
associated with multiple distinct genetic disorders, displaying a wide variation that is 
often anchored by some overlapping phenotypes.  
 
TRAPPC2 variants cause an X-linked recessive skeletal disorder with a male 
preponderance called spondyloepiphysealdysplasia tarda (or late onset) (SEDL) (Gedeon 
et al., 1999). None of the other TRAPP subunits have been linked to this disorder, which 
has been rationalized by a defect in the secretion of extracellular matrix proteins by 
chondrocytes (Venditti et al., 2012). However, individuals with variants of either 
TRAPPC2L (Milev et al., 2018), TRAPPC4 (Van Bergen et al., 2019) TRAPPC6A 
(Mohamoud et al., 2018) or TRAPPC12 (Milev et al., 2017) instead suffer from global 
developmental delay, features of neurodevelopmental disorders and intellectual deficit. 
 
Variants in TRAPPC11 are linked to a spectrum of phenotypes. Their common features 
involve muscular disorders (from limb girdle muscular dystrophy and cardiomyopathy to 
muscular weakness) and intellectual disabilities (Bogershausen et al., 2013; Fee et al., 
2017; Koehler et al., 2017; Larson et al., 2018; Liang et al., 2015; Matalonga et al., 
2017). The implication of TRAPPC11 in learning and memory seem to be a conserved 
function across kingdoms as the Drosophila orthologue gryzun has been linked to long-
term memory (Dubnau et al., 2003). Other phenotypes linked to variants in TRAPPC11 
are fatty liver seen in humans (Bogershausen et al., 2013; Fai Tse et al., 2016; Liang et 
al., 2015) and zebrafish (Cinaroglu et al., 2011; Sadler et al., 2005), achalasia, alacrima, 
scoliosis (Koehler et al., 2017) and cataracts (Liang et al., 2015). 
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Overall, the broad spectrum of cellular phenotypes and clinical features highlights the 
importance of TRAPP complexes in development and cellular function while also 
implicating many of the TRAPP subunits in specialized roles. Further studies are needed 
to tease apart the functions of these proteins within the context of the complex and 
separately from it. 
 
1.5 Role of TRAPP in Autophagy 
 
TRAPP was first linked to autophagy in yeast when a TRAPP III-specific subunit, Trs85, 
which is not essential for cell viability, was shown to be essential in selective and non-
selective autophagy (Meiling-Wesse et al., 2005). Subsequent work demonstrated that 
TRAPP III is recruited to the PAS where it activates and recruits Ypt1 (Lynch-Day et al., 
2010), triggering the subsequent recruitment of Atg1, the yeast homologue of ULK1 
(Wang et al., 2013). Thus, it was proposed that Ypt1 regulates Atg9 vesicle tethering by 
modulating the delivery of Atg1 to the PAS (Wang et al., 2013). However, other studies 
support the idea that Atg9 is binding and recruiting TRAPP III to the PAS. Notably, 
Trs85 co-localizes with Atg9 on the PAS as well as on multiple punctae in the cytosol 
(Lipatova et al., 2012). Mutations in Atg9 affect the formation of the PAS, and therefore 
the recruitment of Trs85 to these membranes will not occur (Kakuta et al., 2012). TRAPP 
III also binds to COPII vesicles at the PAS (Tan et al., 2013), so it is tempting to propose 
that the role of yeast TRAPP III is to recruit membranes (COPII and Atg9) as materials 
for the construction of the elongated isolation membrane.  
 
A specific subunit of yeast TRAPP II, Trs130, was proposed to be involved indirectly in 
autophagy through activation of Ypt31/32 (Zou et al., 2013) which may regulate the 
trafficking of Atg8 and Atg9 from the trans-Golgi to the PAS (Zou et al., 2013). Mutant 
strains of Trs130 or Trs65, another specific subunit of yeast TRAPP II, showed an 
accumulation of Atg8 and Atg9 in the trans-Golgi but not in the PAS, and this phenotype 
was rescued by GTP-bound Ypt31 or Ypt32 but not by Ypt1 nor the GDP-bound form of 
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Ypt31 (Zou et al., 2013), suggesting that TRAPP can affect autophagy directly as well as 
indirectly through its effects on membrane trafficking.  
 
The first evidence of mammalian TRAPP being involved in autophagy was in a 
proteomic analysis of the autophagy interaction network in human cells under conditions 
of basal autophagy (Behrends et al., 2010). In this study it was found that depletion of 
either one of TRAPPC5, TRAPPC8 or TRAPPC11 was followed by a reduction in 
autophagosome formation, while depletion of TRAPPC12 led to an increase in the 
number of autophagosomes. Moreover, TRAPP subunits (TRAPPC11, TRAPPC12, 
TRAPPC8, TRAPPC2L, TRAPPC4 and TRAPPC5) were found in the same sub-network 
as TECPR1, a protein known to be involved in the fusion of the autophagosome with 
lysosomes (Behrends et al., 2010). A subsequent study meant to examine genetic 
modifiers of cellular susceptibility to a toxin called ricin revealed the existence of two 
mammalian TRAPP complexes, TRAPP II and TRAPP III, and found that TRAPP III 
interacts with COPII vesicles (Bassik et al., 2013). Knowing that COPII vesicles 
participate as a source of membrane in the formation of the isolation membrane (Shima et 
al., 2019), it is tempting to suggest that TRAPP III may participate in autophagosome 
formation. A recent study proposed an elegant mechanism through which mammalian 
TRAPP III influences autophagy. The interaction of TBC1D14 from RAB11-positive 
recycling endosomes with TRAPP III triggers the conversion of RAB11-positive 
membranes to RAB1-positive membranes, facilitating endosome-to-Golgi traffic of 
ATG9 vesicles. This mechanism ensures a rapid cycling of ATG9 vesicles under 
starvation and maintains their supply, which is required for autophagosome formation 
(Lamb et al., 2016; Longatti et al., 2012). Interestingly, TRAPPC13 depletion promotes 
cell survival under either induced Golgi stress conditions or mTOR inhibition by 
reducing the rate of autophagy. The mechanism is still unclear, however it seems that the 
effect of TRAPPC13 on the activity of RAB1 becomes a rate-limiting factor for 
autophagy in these stress conditions (Ramirez-Peinado et al., 2017). Similar to yeast, 
mammalian TRAPP III interacts with ATG9, as evidenced by the ability of TRAPPC13 
to immunoprecipitate ATG9 (Ramirez-Peinado et al., 2017). It is not clear how 
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TRAPPC13 is involved in binding ATG9 without affecting cell survival, when it is 
known that ATG9 is essential for the initiation of autophagy (Lamb et al., 2016).  	
1.6 Objectives 
 
Objective 1- Determine the role of TRAPPC11 in autophagy. 
 
Much more is known about the involvement of the yeast TRAPP III complex in secretion 
and autophagy than its mammalian counterpart. While yeast TRAPP III has just a single 
non-core subunit, Trs85, mammalian TRAPP III has four additional subunits: TRAPPC8; 
TRAPPC11; TRAPPC12; and TRAPPC13. There is low sequence similarity between 
TRAPPC8 and Trs85, and no yeast homologue exists for TRAPPC11 nor for 
TRAPPC12. There is evidence that TRAPPC12 participates in the retrograde trafficking 
of ATG9 from peripheral recycling endosomes to the early Golgi (Lamb et al., 2016). 
The role of mammalian TRAPP III in autophagy, a process affected by membrane 
trafficking, needs to be deciphered and so I made this my first goal, with a principal focus 
on TRAPPC11. The findings were published in Traffic and are shown here in Chapter 2. 
 
Objective 2- Identification of other roles of TRAPPC11 in the cell. 
 
It has been previously published that depletion of (Scrivens et al., 2011) or mutations in 
(Bogershausen et al., 2013; Fee et al., 2017; Koehler et al., 2017; Larson et al., 2018; 
Liang et al., 2015; Matalonga et al., 2017) TRAPPC11 affect membrane traffic. In 
Chapter 2 I show that TRAPPC11 is important in the recruitment of ATG2 and WIPI4, 
proteins involved in elongation of the isolation membrane (Stanga et al., 2019). 
Interestingly, TRAPPC11 can also function independent of the complex in the formation 
of lipid-linked oligosaccharides in N-glycosylation (DeRossi et al., 2016). Individuals 
with variants in TRAPPC11 harbour a spectrum of phenotypes including neuromuscular 
defects and intellectual deficiency, with features including scoliosis, alacrima, steatosis, 
cerebral atrophy, and fatty liver. My hypothesis was that this spectrum of phenotypes is 
due to the multiple roles of TRAPPC11 in different cellular functions, including 
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membrane traffic, autophagy and glycosylation, and thus individuals with mutations in 
the same region will display similar phenotypes. The results of this study were published 




Chapter 2: TRAPPC11 Functions in Autophagy by Recruiting ATG2B-
WIPI4/WDR45 to Preautophagosomal Membranes. 	
This Chapter was published as a manuscript in the journal Traffic (Stanga et al., 2019). I 
am responsible for the all figures except Figure 2.7A and Supplemental Figure 2.4A and 
B in which I prepared the treatment for the cells and Dr. Milev stained them and analyzed 




TRAPPC11 has been implicated in membrane traffic and lipid-linked oligosaccharide 
synthesis, and mutations in TRAPPC11 result in neuromuscular and developmental 
phenotypes. Here, we show that TRAPPC11 has a role upstream of autophagosome 
formation during macroautophagy. Upon TRAPPC11 depletion, LC3-positive 
membranes accumulate prior to, and fail to be cleared during, starvation. A proximity 
biotinylation assay identified ATG2B and its binding partner WIPI4/WDR45 as 
TRAPPC11 interactors. TRAPPC11 depletion phenocopies that of ATG2 and WIPI4 and 
recruitment of both proteins to membranes is defective upon reduction of TRAPPC11. 
We find that a portion of TRAPPC11 and other TRAPP III proteins localize to isolation 
membranes. Fibroblasts from a patient with TRAPPC11 mutations failed to recruit 
ATG2B-WIPI4, suggesting that this interaction is physiologically relevant. Since 
ATG2B-WIPI4 is required for isolation membrane expansion, our study suggests that 
TRAPPC11 plays a role in this process. We propose a model whereby the TRAPP III 





Macroautophagy (autophagy) is a basal process in cells that removes damaged organelles 
and ensures a ready supply of amino acids for protein synthesis. This process is 
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upregulated during starvation when nutrients are scarce. Autophagy starts with the 
nucleation of membranes referred to as the phagophore assembly site in yeast or isolation 
membranes in higher eukaryotes. The expansion of the isolation membrane is due in part 
to the input of membranes from sources including mitochondria, the endoplasmic 
reticulum (ER), mitochondria-ER contact sites, the plasma membrane and endosomes 
(Axe et al., 2008; Hailey et al., 2010; Hamasaki et al., 2013a; Hayashi-Nishino et al., 
2009; Ravikumar et al., 2010a; Young et al., 2006). Upon sealing of the isolation 
membrane into a fully enclosed, double-membrane-bound autophagosome, its cargo is 
delivered to the lysosome by autophagosome-lysosome fusion creating autolysosomes 
where the degradative enzymes of the lysosome hydrolyze the contents of the 
autophagosome to help re-establish a pool of cellular nutrients. 
 
Proteins acting at various stages of autophagy (ATG) have been identified by genetic 
screens in yeast and many of these proteins are conserved throughout evolution (Levine 
and Klionsky, 2017). Much effort has been put into defining the sequence of events in 
autophagy. Nucleation is initiated by the action of the ULK1 kinase, which activates a 
phosphatidylinositol-3 kinase-containing complex (Russell et al., 2013). The resulting 
phosphatidylinositol-3-phosphate (PI(3)P)-rich membranes of the ER subdomain called 
the omegasome serve as a platform to recruit ATG5-ATG12-ATG16L1, a complex 
required to lipidate LC3-I, converting it into the autophagy-specific LC3-II (Ichimura et 
al., 2000). Isolation membrane expansion requires other ATG proteins including ATG2 
(Kishi-Itakura et al., 2014), a protein that interacts with a PI(3)P effector called 
WIPI4/WDR45 (hereafter WIPI4) (Bakula et al., 2017; Baskaran et al., 2012; Behrends et 
al., 2010; Zheng et al., 2017). Little is known about how the isolation membrane is sealed 
into a mature autophagosome, although ATG5 and members of the LC3/GABARAP 
family have been implicated in this process (Kishi-Itakura et al., 2014; Weidberg et al., 
2010). Identifying novel regulators of these key autophagy proteins will be of importance 
for a more complete understanding of this process. 
 
TRAPP is a family of multisubunit complexes implicated in membrane trafficking that 
were first identified in yeast and are also found in higher eukaryotes (Bassik et al., 2013; 
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Lynch-Day et al., 2010; Riedel et al., 2018; Sacher et al., 2001; Sacher et al., 1998). Each 
complex is composed of an identical core of proteins, and additional, complex-specific 
proteins define their identity, localization and function (Brunet and Sacher, 2014; Kim et 
al., 2016). Most of the subunits of the complexes are conserved throughout evolution but 
metazoa have several subunits not found in Saccharomyces cerevisiae including 
TRAPPC11 and TRAPPC12 (Scrivens et al., 2011). These latter two subunits are 
components of TRAPP III that also contains TRAPPC8 and TRAPPC13 (Bassik et al., 
2013). While a role for yeast TRAPP III in autophagy is established (Brunet et al., 2013; 
Kakuta et al., 2012; Lipatova et al., 2012; Lynch-Day et al., 2010; Shirahama-Noda et al., 
2013; Taussig et al., 2014), the role of the human complex in this process is not well 
understood. A proteomics study initially implicated human TRAPP III in autophagy 
(Behrends et al., 2010), and several recent studies have further shown a role for TRAPP 
III in this process (Lamb et al., 2016; Ramirez-Peinado et al., 2017).  
 
To date, two of the human TRAPP III-specific proteins (TRAPPC11 and TRAPPC12) 
have been implicated in cellular processes distinct from membrane trafficking. These 
include lipid-linked oligosaccharide synthesis for TRAPPC11 and chromosome 
congression for TRAPPC12 (DeRossi et al., 2016; Milev et al., 2015). In addition, both 
proteins have been implicated in human disease that manifests as muscular and 
neurodevelopmental phenotypes (Bogershausen et al., 2013; Fee et al., 2017; Koehler et 
al., 2017; Larson et al., 2018; Liang et al., 2015; Matalonga et al., 2017; Milev et al., 
2017). Given the overall size of the TRAPP complexes (Kim et al., 2006; Tan et al., 
2013; Yip et al., 2010), it is not unreasonable to expect their constituent proteins to have 
unique interacting partners, thereby allowing the complexes to coordinate distinct events 
even within a common pathway. Thus, understanding the various roles that the TRAPP 
proteins play in cell physiology will shed light on the diseases caused by mutations in 
their genes. 
 
Here, we show that the TRAPP III-specific proteins TRAPPC11, TRAPPC12 and 
TRAPPC8 affect autophagy. While depletion of TRAPPC8 affected the formation of 
isolation membranes, TRAPPC11 and TRAPPC12 functioned downstream of this step. 
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We show that TRAPPC11 interacts with ATG2B, one of the ATG2 homologs, as well as 
with its binding partner WIPI4. TRAPPC11 depletion phenocopies that of both ATG2 
and WIPI4 resulting in unsealed isolation membranes, suggesting that TRAPPC11 
functions upstream of isolation membrane closure. In contrast, TRAPPC12 functions 
after autophagosome formation. We demonstrate that the recruitment of ATG2B and 
WIPI4 to isolation membranes is dependent upon TRAPPC11 and implicate the carboxy-
terminus of TRAPPC11 as important for this recruitment. Fibroblasts from an individual 
with bi-allelic TRAPPC11 mutations including one at the carboxy-terminus are defective 
in ATG2B and WIPI4 recruitment. This defect in the fibroblasts was suppressed by wild 
type TRAPPC11, suggesting that this newly identified interaction is important in human 
health. We propose a model whereby different TRAPP III proteins participate in various 
steps in autophagy including isolation membrane formation and expansion, thus 
implicating TRAPP III in a key role in early autophagy events. 
 
2.3 Materials and Methods 	
2.3.1 Cell Culture 
 
HeLa cells stably expressing the autophagosomal marker mRFP/GFP-LC3 (Sarkar et al., 
2009) and primary fibroblasts were cultured in Dulbecco's modified Eagle medium 
(DMEM) (Wisent, St. Bruno, Quebec, Canada) supplemented with 10% (vol/vol) fetal 
bovine serum (FBS; Thermo Fisher Scientific, Waltham, Massachusetts) at 37°C in a 
humidified incubator with 5% CO2. 
 
2.3.2 Starvation Treatments 
 
The cells were seeded in 6- or 10-cm diameter dishes, washed twice with phosphate-
buffered saline (PBS) and incubated with EBSS (Wisent, St. Bruno, Quebec, Canada) for 
the times indicated in each figure. In some cases, 200 nM Bafilomycin A1 (Sigma-
Aldrich, St. Louis, Missouri) was included during a 2-hour starvation to block the fusion 
of autophagosomes with lysosomes. Proteolytic activity of lysosomes was inhibited by 
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including both 10 µM E64d (Sigma-Aldrich, St. Louis, Missouri) and 10 µM pepstatin A 
(Sigma-Aldrich, St. Louis, Missouri) for 3 hours. In some instances, cells starved and 
treated with Bafilomycin A1 were returned to nutrient-rich medium by washing the cells 
twice with PBS and incubating in DMEM with 10% FBS for 20 or 40 minutes. The cells 
were either lysed by harvesting in lysis buffer (150 mM NaCl, 50 mM Tris pH 7.2, 1 mM 
DTT, 1% Triton X-100, 0.5 mM EDTA, Complete protease inhibitors (Roche, Basel, 
Switzerland) and analyzed by western blotting, or plated on 18-mm glass coverslips pre-
coated with poly-L-lysine (Thermo Fisher Scientific, Waltham, Massachusetts) for 
immunostaining, or plated on 35-mm glass-bottom four micro-well separation dishes 
(Greiner, Kremsmunster, Austria) for time-lapse microscopy. 
 
2.3.3 Transfection and RNA Interference 
 
Transfection of siRNAs (Table 2.1) was performed using JetPrime (Polyplus, Illkirch, 
France) as per the manufacturer's protocol. Sixteen hours prior to transfection, the cells 
were seeded at 80% confluence. For TRAPPC12 knockdown, cells were incubated with 
20nM siRNA for 24 hours. For TRAPPC11, TRAPPC8, TRAPPC2, ATG9A, WIPI4 and 
ATG2 knockdowns the cells were transfected with 20nM siRNA on day 1, passaged 1:2 
on day 2, and re-transfected with siRNA on day 3. The rescue experiments in HeLa cells 
were performed using siRNA resistant BirA-FLAG-C11 and C11-FLAG-BirA. HeLa 
cells at 80% confluence were transfected with 20nM TRAPPC11 siRNA, passaged after 
24 hours to 50% confluence on a 10-cm dish and transfected with 20nM TRAPPC11 
siRNA and 10 µg of DNA. The cells were harvested after 48 hours and processed for 
membrane recruitment of ATG2B as described below. The constructs used in the rescue 
experiment in primary fibroblasts were introduced into the cells by electroporation using 
the Neon Transfection System (Thermo Fisher Scientific, Waltham, Massachusetts). In 
this case, 1 µg of DNA was used per transfection and the cells were subjected to 1600 V 




2.3.4 Time-lapse Microscopy 
 
For live-cell imaging, HeLa cells stably expressing mRFP-GFP-LC3 were plated in 35-
mm glass-bottom dishes. Time-lapse microscopy was performed after transfection using 
a 60Å~ (NA 1.4) or 100Å~ (NA 1.46) oil immersion objective, no binning, on an 
inverted confocal microscope (Live Scan Swept Field; Nikon, Tokyo, Japan), Piezo Z 
stage (Nano- Z100N; Mad City Labs, Inc., Madison, Wisconsin), and an electron 
multiplying charge-coupled device camera (512 Å~ 512; iXon X3; Andor Technology, 
Belfast, United Kingdom). The microscope was equipped with an environmental chamber 
heated to 37°C with 5% CO2. Images were acquired with NIS-Elements Version 4.0 
acquisition software every 10 minutes using a 0.2 second exposure at 0.3 µm increment 
sizes. Images were deconvolved with AutoQuant X3 software (Media Cybernetics, 
Rockville, Maryland) and analyzed on Imaris version 7.6 (Bitplane, Belfast, United 
Kingdom) and ImageJ (National Institutes of Health). For measuring the fusion of 
autophagosomes a Zeiss LSM 880 Airyscan microscope with a 100Å~ (NA 1.4) oil 
immersion objective was used. Images were acquired every 20 seconds for 15 minutes at 
0.3 µm increment sizes. The vesicles were tracked over time and the intensities of GFP 
and RFP were measured using Imaris. 
 
2.3.5 Immunofluorescence Microscopy 
 
The cells were gently washed with PBS then fixed with 4% paraformaldehyde (PFA) for 
20 minutes at room temperature, quenched with 0.1 M glycine for 10 minutes and 
permeabilized with 0.1% Triton X-100 for 7 minutes. The cells were then blocked in 5% 
normal goat serum (Cell Signaling Technology, Danvers, Massachusetts) in PBS for 40 
minutes at room temperature. Primary antibodies (Table 2.2) were diluted in 5% normal 
goat serum and were added to coverslips and incubated for 16 hours at 4°C. Cells were 
then washed three times with PBS for 10 minutes per wash. DAPI was added during the 
first wash at a final concentration of 0.1 µg/mL. Cross-adsorbed secondary antibodies 
(Life Technologies, Carlsbad, California; see Table 3) were diluted in 5% normal goat 
serum in PBS and applied for 1 hour at room temperature. Coverslips were washed three 
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times with PBS for 10 minutes per wash, mounted with Prolong Gold AntiFade reagent 
(Life Technologies, Carlsbad, California), and sealed with nail polish. 12-bit images 
(1024 Å~ 1024-pixel resolution) were recorded on an Olympus Fluoro View Confocal 
Laser Scanning microscope. The images were acquired with a 0.3 µm increment size. 
 
2.3.6 Western Blotting 
 
Samples (7 µg total protein for LC3 analysis or 30 µg total protein for all other proteins) 
were analyzed on either 8% or 15% SDS polyacrylamide gels. The proteins were 
transferred to nitrocellulose membranes (BioRad, Hercules, California) for ATG2B or 
polyvinylidene difluoride (PVDF) membrane (Millipore, Burlington, Massachusetts) for 
all other proteins for 1 hour at 100 V. Membranes were blocked with 5% skimmed milk 
powder in PBS-T (PBS with 0.1% Tween 20 [vol/vol]) for 1 hour. The primary and 
secondary antibodies used, and their dilutions, are listed in Table 2.2. Primary antibodies 
were incubated in PBS-T overnight and secondary antibodies were incubated for 1 hour. 
Membranes were then incubated with ECL reagent (GE Healthcare, Chicago, Illinois) 




HeLa cells (107 cells/10 cm dish) were washed twice with PBS and lysed in 1 mL of ice-
cold RIPA buffer (10 mM Tris-Cl pH 8.0, 1 mM EDTA, 1% Triton X-100, 0.1% sodium 
deoxycholate, 140 mM NaCl, Complete protease inhibitors (Roche, Basel, Switzerland)). 
The lysate was clarified at 14000Å~g in a precooled microcentrifuge for 15 minutes. A 
total of 500 µg of lysate was incubated with 30 µL of protein A-agarose beads (50% 
slurry) (Bioshop Canada) at 4°C for 30 minutes on an orbital shaker. The agarose beads 
were removed by a brief centrifugation at 5000 rpm in a refrigerated microfuge for 30 
seconds. The cleared lysate was incubated overnight at 4°C with 10 µg of TRAPPC11 
antiserum. Immune complexes were captured by adding 30µL protein A-agarose bead 
slurry (blocked with 5% BSA in PBS-T) and gently rocking on an orbital shaker 
overnight at 4°C. The beads were collected by a brief centrifugation at 5000 rpm in a 
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refrigerated microfuge for 30 seconds and washed 3 times with 1 mL ice-cold PBS-T. 
The beads were resuspended in 60 µL 2Å~ Laemmli sample buffer and heated at 95°C 
for 5 minutes to dissociate the immunocomplexes. The beads were pelleted by 
centrifugation and SDS-PAGE was performed with the supernatant fraction. 
 
2.3.8 Subcellular Fractionation and Proteinase K Treatment 
 
Subcellular fractionation and treatment of lysates with proteinase K was performed 
essentially as described in (Velikkakath et al., 2012). Briefly, cells were seeded at full 
confluence on six-well dishes. HeLa cells were treated with siRNA as indicated in the 
figure and were cultured in either DMEM with 10% FBS (non-starved) or EBSS 
containing 200 nM Bafilomycin A1 for 2 hours (starved and autophagosome lysosome 
fusion-impaired). Cells were then collected and homogenized in 250 µL homogenization 
buffer (10 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid [HEPES]-KOH pH 
7.4, 0.22 M mannitol, 0.07 M sucrose, and protease inhibitors) by 10 cycles using a 
syringe with a 27 gauge needle. The post-nuclear supernatant was obtained by 
centrifugation at 300Å~g for 5 minutes in a refrigerated microfuge. A total of 150 µg of 
PN was further centrifuged at 7700Å~g for 5 minutes in a refrigerated microfuge to 
generate the low-speed pellet (LP). The resulting supernatant was centrifuged at 
100000Å~g for 30 minutes in a table-top ultracentrifuge in a TLA100 rotor to generate a 
high-speed pellet (HP) and a high speed supernatant (HS). The LP and HP were 
resuspended in the same volume of homogenization buffer. To analyze the integrity of 
the membranes, the LP and HP (250 µL) were either left untreated or incubated with 100 
µg/mL proteinase K (Invitrogen, Carlsbad, California) with or without 1% Triton X-100 
on ice for 30 minutes. All samples (LP, HP and HS) were precipitated by incubating in 
10% trichloroacetic acid (TCA) on ice for 30 minutes, washed with ice-cold 
homogenization buffer and resuspended in 1X Laemmli sample buffer. The resulting 
sample was then heated to 95°C for 5 minutes and analyzed by SDS-PAGE followed by 
western analysis for the indicated proteins. Primary fibroblasts were processed as 
described for the HeLa cells. 
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2.3.9 ATG2 Recruitment Assay 
 
Cells were seeded at full confluence on 10 cm dishes and mechanically lysed as described 
above. A PN was produced as described above and a total of 500 µg of PN was 
centrifugated at 7700Å~g for 30 minutes to generate the LP. The resulting supernatant 
fraction was centrifuged at 100000Å~g for 2 hours in a table-top ultracentrifuge in a 
TLA100 rotor to generate HP and HS fractions. The LP and HP were washed with ice-
cold homogenization buffer to remove all traces of non-membrane-bound proteins and 
resuspended in 1X Laemmli sample buffer. The HS was precipitated with TCA as above, 
washed with homogenization buffer and resuspended in sample buffer. Samples were 
heated to 95°C for 5 minutes prior to western analysis. 
 
2.3.10 Proximity Biotinylation (BioID) 
 
The Flp-In/T-REx 293 cell line from Life Technologies was used to generate BioID cell 
lines with BirA fusion proteins (Roux et al., 2012). Parental cells were seeded in a 10 cm 
dish with 15ug/mL blasticidin 1 day before transfection to obtain 70% confluency on the 
day of transfection. Transfections were performed using Jetprime (Polyplus, Illkirch, 
France) containing 1.5 µg BirA construct (C11-BirA or BirA-C11 in 
pDEST_pcDNA5_BirA-FLAG_C-term or pDEST_pcDNA5_BirA-FLAG_N-term, 
respectively, produced by Gateway cloning) and 13.5 µg pOG44. Transfected cells were 
incubated in a 37°C incubator for 24 hours before changing the medium with fresh 
antibiotic-free DMEM containing 10% FBS. The following day, cells were passaged at 
1:4 dilution (~25% confluence) onto two 10 cm dishes in medium containing 100 µg/mL 
hygromycin and 15 µg/mL blasticidin. The medium was changed every 2 to 3 days 
during the 2-week selection until colonies were visible. The colonies were pooled to 
obtain a polyclonal cell line, which was expanded in medium containing hygromycin and 
blasticidin. Two control cell lines were generated with pDEST_pcDNA5_BirA-
FLAG_N-term or pDEST_pcDNA5_BirA-FLAG_C-term plasmids followed by selection 
as described above. To obtain purified TRAPPC11-interacting proteins, BirA-C11 and 
C11-BirA cell lines were grown in 15 cm dishes. At 60% confluency, they were treated 
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with 50 ng/mL tetracycline for 16 hours at which time the medium was changed and 
supplemented with 20% FBS, 50 ng/mL tetracycline and 50 µM biotin. After 8 hours, 
cells were pelleted and lysed in ice-cold RIPA buffer (50 mM Tris pH 7.4, 150 mM 
NaCl, 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 1 mM EDTA) supplemented 
with complete-mini protease inhibitor cocktail (Roche, Basel, Switzerland), 1 mM PMSF, 
62.5 Units/ml benzonase, and incubated at 4°C for 1 hour. Samples were sonicated in a 
4°C ice bath (4 bursts of 10 seconds on low power). After sonication, samples were 
centrifuged at 4°C for 30 minutes at 13200 rpm in a refrigerated microfuge. Supernatants 
were incubated with 14 µL streptavidin-Sepharose beads (Sigma) per dish at 4°C for 3 
hours to capture the denatured biotinylated proteins. After the incubation, beads were 
washed five times with RIPA and four times with low detergent buffer (25 mM Tris pH 
7.4, 100 mM NaCl, 0.025% SDS). Following the last wash, beads were pelleted and 
analyzed by mass spectrometry as previously described (Brunet et al., 2016) to identify 
proteins captured by the BioID purification. Data were analyzed using Scaffold 4 
proteomic software. 
 
Table 2.1 List of siRNAs used in this study 
Targeted gene Sense sequence (5ʹ→3ʹ) Source 
TRAPPC2 UCCAUUUUAUGAACCCAAUTT Life Technologies 
TRAPPC8 CAGCUCUCCUAAUACGGUUTT Life Technologies 
TRAPPC11 GGAUUUAUAAACUACAAGGATT Life Technologies 
TRAPPC12 CGGACAAGCUGAACGAACATT Life Technologies 
ATG2A GCAUUCCCAGUUGUUGGAGUUCCUA Life Technologies 
ATG2B AGGUCUCUCUUGUCUGGCAUCUUUA Life Technologies 
WDR45/WIPI4 CCAGTGATAAGGGTACTGTCCATAT Life Technologies 








Table 2.2 List of antibodies used in this study 
 
Antigen Type Host IF dil WB dil Size 
(kDa) 
Source Catalog 
TRAPPC2 P r N/A 1:1000 16 Sacher L N/A 
TRAPPC8 P r N/A 1:500 160 Abcam Ab122692 
TRAPPC10 M m N/A 1:1000 130 Abnova H00007109-
M01 
TRAPPC11 P r N/A 1:1000 129 Sacher L N/A 
TRAPPC12 P r N/A 1:2500 78 Sacher L N/A 




















P r N/A 1:2500 48 Abcam ab155686 
ATG2B P r 1:500 1:1000 240 Abcam ab116215 

















ATG9A M r 1:300 1:1000 95 Abcam ab108338 
FLAG M m 1:300 1:5000 N/A Sigma-
Aldrich 
F3165 
Cathepsin B M m N/A 1:1000 24-31 Abcam ab58802 
LAMP1 P r 1:300 N/A N/A Abcam 
 
ab24170 






HCA g 1:500 N/A N/A A-11034 Life 
Technologies 
Alexa Fluor 
488   anti–
mouse 















HCA g 1:500 N/A N/A A-21235 Life 
Technologies 
 
IF, immunofluorescence, g, goat; HCA, highly cross-adsorbed; M, monoclonal; m, 
mouse; N/A, not applicable; P, polyclonal; r, Rabbit; WB, western blot. 
∗molecular size of the ATG12-ATG5 conjugate 
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2.4 Results 	
2.4.1 Depletion of TRAPP III Proteins Affects Autophagic Flux 
 
To begin to address the role of TRAPP III proteins in autophagy, we first examined the 
appearance of the autophagy-specific form of endogenous LC3 (LC3-II) in HeLa cells 
depleted of TRAPP III proteins by small interfering RNA (siRNA) (Figure 2.1A and 
Figure S1.1A). While control cells showed an increase in LC3-II levels after 2 hours of 
starvation that decreased by 4 hours, cells that were depleted of TRAPPC11 showed 
elevated levels of LC3-II prior to starvation and the increased levels persisted over the 4 
hour time course of starvation. Similar results were seen for TRAPPC12-depleted cells. 
In contrast, and as previously reported (Behrends et al., 2010; Imai et al., 2016), 
TRAPPC8 depletion blocked the formation of LC3-II, consistent with TRAPPC8 
functioning upstream of both TRAPPC11 and TRAPPC12. A similar result was noted for 
TRAPPC2-depleted cells, the core TRAPP subunit that acts as an adaptor for TRAPPC8 
(Brunet et al., 2013; Zong et al., 2011). The cells also contain mRFP-GFP-LC3 and we 
monitored them for the number of GFP-positive structures during starvation (Figure 2.1B 
and C). Consistent with the results in Figure 2.1A, both TRAPPC11- and TRAPPC12-
depleted cells had a large number of GFP-positive punctae prior to starvation that did not 
significantly change over the 4 hours of starvation. TRAPPC8- and TRAPPC2-depleted 
cells did not show any starvation-dependent increase in the number of GFP-positive 
punctae compared to control cells. We then examined the formation of autolysosomes 
upon depletion of the TRAPP III proteins in the mRFP-GFP-LC3 cell line. Fusion of 
autophagosomes with lysosomes ultimately results in quenching of the GFP fluorescence 
in the more acidic environment, resulting in red punctae. If fusion is blocked, both a red 
and green (yellow) punctum is seen (Kimura et al., 2007). As shown in Figure 2.1D and 
quantified in Figure 2.1E, prior to starvation, control cells have few punctae, some of 
which are red. Upon starvation, there is a large increase in these structures and a large 
portion of them are red, indicating that autolysosome formation has taken place. 
Formation of autolysosomes was blocked by the inclusion of Bafilomycin A1, resulting 
in yellow punctae. In contrast to the control, when either TRAPPC11 or TRAPPC12 was 
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depleted, we observed a large number of yellow but few red punctae both prior to and 
following starvation even in the absence of Bafilomycin A1, indicating that these 
structures have not fused with lysosomes. Depletion of TRAPPC8 resulted in 
substantially fewer punctae, consistent with a defect in autophagosome formation. 
Defective autolysosomes formation in TRAPPC11- and TRAPPC12-depleted cells was 
also seen by examining the lifetime of the GFP-LC3 fluorescence (Figure S1.1B). 
Individual punctae were monitored over a 120 second time frame and the intensity of the 
GFP fluorescence, which is a measure of autophagosome-lysosome fusion, was assessed. 
While the majority of punctae in control cells showed a fluorescence intensity of 20% of 
the initial (t = 0) intensity or lower, the majority of the punctae in both TRAPPC11- and 
TRAPPC12-depleted cells were between 30% and 50% of the initial intensity, consistent 
with a defect in autophagic flux. In addition, the diameter of these structures in 
TRAPPC11-depleted cells was larger than those seen in control cells (Figure S1.1C). 
Although the diameter of the structures in TRAPPC12-depleted cells was similar to that 
of control cells, we noted a population of punctae that were larger in diameter. The 
reason for these larger structures is unknown. We then assessed the ability of HeLa cells 
to clear autophagosomes that were formed in the presence of the autophagosome-
lysosome fusion inhibitor Bafilomycin A1. Cells were starved for 2 hours in the presence 
of the inhibitor and then transferred to nutrient-rich medium for up to 40 minutes and the 
effect on LC3-II was monitored throughout (Figure 2.1F). In control cells, LC3-II was 
highest following treatment with Bafilomycin A1, and was then rapidly cleared by the 40 
minute time point. In contrast, both TRAPPC11- and TRAPPC12-depleted cells did not 
show any significant clearance of the Bafilomycin A1-induced LC3-II. In TRAPPC8-
depleted cells, we were unable to detect significant levels of LC3-II. Collectively, our 
data suggest that the TRAPP III proteins TRAPPC11, TRAPPC12 and TRAPPC8 are 
involved in autophagic flux, but the former two may be acting downstream of TRAPPC8. 
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Figure 2.1 Depletion of TRAPPC11 affects autophagic flux 
(A) HeLa cells expressing mRFP-GFP-LC3 were subjected to a knockdown with either 
non-specific (NS) small interfering (siRNA), or siRNA targeting TRAPPC2, TRAPPC8, 
TRAPPC11 or TRAPPC12. The cells were then placed in starvation (EBSS) medium for 
the indicated time (in hours). At each time point, lysates were prepared, fractionated on 
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an SDS-polyacrylamide gel, transferred to PVDF and probed for endogenous LC3 and 
tubulin. The resulting bands were quantified using Image J and plotted as the ratio of 
LC3-II to tubulin. Results reflect data from three separate experiments with SEM 
indicated. Representative immunoblots are shown below the graphs. (B, C) HeLa cells 
stably expressing mRFP-GFP-LC3 were treated as in panel (A), transferred into 
starvation (EBSS) medium and imaged every 10 minutes for three hours. GFP-LC3-
positive structures were counted using Imaris software and plotted in Graphpad Prism. A 
total of 10 cells were quantified at each time point in (C). The times above the panels in 
(B) indicate the time in starvation (EBSS) medium. (D) HeLa cells stably expressing 
mRFP-GFP-LC3 were left untreated or treated with siRNA as in (A). The cells were then 
either left in nutrient-rich (DMEM) medium or transferred to starvation (EBSS) medium 
for 3 hours either with or without 200 nM Bafilomycin A1. Panels from the merged GFP 
and RFP channels are shown. (E) Quantification of the red (autolysosome) and yellow 
(isolation membrane or autophagosome) punctae from panel (D) was performed on a 
minimum of 10 cells. The error bars indicate SEM. (F) HeLa cells were treated as in (A). 
One sample also received 200 nM Bafilomycin A1 for 2 hours (2B). The Bafilomycin 
A1-treated cells were then transferred into fresh nutrient-rich (DMEM) medium for up to 
40 minutes. Lysates were prepared and processed for western analysis and representative 
immunoblots are shown below each graph. The scale bars in panels (B) and (D) are 20 
µm. Numbers to the right of immunoblots denote the migration of molecular size 
standards in kD. The extent of each of the knockdowns is shown in Figure S1.1. 
 
2.4.2 TRAPPC11 Interacts with ATG2B-WIPI4 
 
Given the involvement of TRAPPC11 in disease, we decided to focus on this protein to 
better understand its role in human health. We employed a biotin proximity ligation 
screen (BioID) to identify interacting partners that might help to elucidate the role of 
TRAPPC11 in autophagy (Roux et al., 2012). The screen was performed with both an 
amino- and carboxy-terminal fusion protein of TRAPPC11 with the BirA biotin ligase 
(BirA-C11 and C11-BirA, respectively), and it was done two times to verify the accuracy 
of the partners identified. As expected, a number of TRAPP III subunits were identified 
including TRAPPC8, TRAPPC12 and TRAPPC13 (Table 2.3). Interestingly, peptides for 
both TRAPPC8 and TRAPPC13 were identified more robustly with the C11-BirA 
construct compared with BirA-C11, suggesting that these proteins may interact with the 
amino-terminus of TRAPPC11. Strikingly, besides TRAPPC11 itself, peptides derived 
from the autophagy protein ATG2B were the most abundant identified. These peptides 
were nearly all detected using the BirA-C11 construct, suggesting that ATG2B interacts 
with the carboxy-terminus of TRAPPC11. We also identified peptides from WIPI4, a 
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protein that forms a complex with ATG2B. Like ATG2B, these peptides were 
preferentially identified by the BirA-C11 construct (Table 2.3). 
 
Table 2.3 Proteins identified and corresponding peptide count in a proximity 
biotinylation screen with TRAPPC11 




Cell lines stably expressing BirA-TRAPPC11 (BirA-C11) or TRAPPC11-BirA (C11-
BirA) were generated in Flp-In T-Rex 293 cells. The cell lines and controls (just 
expressing BirA) were treated with tetracycline to induce expression of the BirA 
constructs and supplemented with biotin. Lysates were prepared, the biotinylated proteins 
were captured on streptavidin-agarose beads and processed for mass spectrometric 
analysis. The experiment was performed on two separate occasions and the number of 
total peptides and unique peptides was quantified. Note that in all cases except for 
ATG2B in C11-BirA the background was 0 peptides. In the stated exception, the 
background exceeded the experimental case. 
 
We next examined whether TRAPPC11 depletion in HeLa cells results in a similar 
phenotype to ATG2 and WIPI4 depletion. Note that both ATG2 paralogues, ATG2A and 
ATG2B, were depleted because a previous study showed that these proteins may have a 
redundant function (Velikkakath et al., 2012). When compared with control, the 
TRAPPC11, ATG2 and WIPI4 depletions showed elevated levels of LC3-II prior to 
starvation (Figure 2.2A and quantified in Figure S2.2). These levels increased slightly 
during starvation. The phenotype was not further exaggerated by a double 
TRAPPC11/ATG2 or TRAPPC11/WIPI4 depletion, or by a triple 
TRAPPC11/ATG2/WIPI4 depletion. A similar result was seen for depletion of 
Protein 
Total peptides Unique peptides 
BirA-C11 C11-BirA BirA-C11 C11-BirA 

































































TRAPPC12, but depletion of TRAPPC8 did not result in detectable levels of LC3-II 
consistent with our earlier result (Figure 2.2F). The latter phenotype was similar to that of 
depletion of ATG9A, a protein that acts early in autophagy and blocks formation of 
isolation membranes (Orsi et al., 2012). Using HeLa cells expressing mRFP-GFPLC3, 
we found that, as previously reported (Velikkakath et al., 2012), ATG2 depletion resulted 
in an increased number of GFP-LC3 punctae that were generally larger in size compared 
to those in control cells and were seen even prior to starvation (Figure 2.2B and C). These 
structures persisted over a 5-hour starvation period. A similar phenotype was noted upon 
depletion of either of TRAPPC11, TRAPPC12 or WIPI4. In contrast, the phenotype 
resulting from depletion of TRAPPC8 was similar to that of ATG9A depletion where few 
if any GFP-positive punctae were seen. It was previously shown that many of the LC3-
positive punctae that result from ATG2 depletion are also positive for autophagy proteins 
that are components of functional complexes including ULK1, WIPI1, ATG5, ATG14 
and ATG9 (Velikkakath et al., 2012). Similarly, we found that depletion of TRAPPC11 
and WIPI4 also result in LC3-positive structures that co-localize with these early-acting 
autophagy proteins (Figure 2.2D). Therefore, by several different criteria we find that 




Figure 2.2 TRAPPC11 depletion phenocopies an ATG2B or WIPI4 depletion. 
(A) HeLa cells were treated with non-specific (NS) siRNA or siRNA targeting either 
TRAPPC11, TRAPPC12, TRAPPC8, ATG2A and ATG2B (ATG2), WIPI4, ATG9A, 
both TRAPPC11 and ATG2 or WIPI4, or siRNA targeting the three transcripts 
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TRAPPC11, ATG2 and WIPI4. The cells were left in nutrient-rich (DMEM) medium or 
transferred into starvation (EBSS) medium for 2 hours with or without the protease 
inhibitors E64d and pepstatin A. Lysates were prepared and the levels of LC3 and tubulin 
were detected by western analysis. (B) HeLa cells were treated with non-specific (NS) 
siRNA or siRNA targeting the indicated transcripts. The cells were then transferred to 
starvation (EBSS) medium for the times indicated. The cells were then fixed and stained 
with anti-LC3 antibody. (C) The number of LC3-positive punctae in panel (B) were 
quantified using Imaris from deconvoluted images and plotted. A total of 25 cells at each 
time point were used in the quantification. Error bars indicate SEM. (D) HeLa cells or 
HeLa cells expressing GFP-tagged ULK1, WIPI1, ATG5 or ATG14 as indicated in the 
figure were treated with non-specific (NS) siRNA or siRNA targeting either TRAPPC11, 
ATG2 or WIPI4. The cells were then stained for LC3 or, in the case of HeLa cells, LC3 
and ATG9A. Endogenous GFP fluorescence or ATG9A fluorescence was imaged and 
overlayed onto the LC3 fluorescent signal. The scale bars in (B) and (D) represent 20 µm. 
Numbers to the right of the immunoblots denote the migration of molecular size 
standards in kD. 
 
2.4.3 Depletion of TRAPPC11 Results in Unsealed Isolation Membranes 
 
Because ATG2 proteins function prior to the sealing of isolation membranes into 
enclosed autophagosomes (Kishi-Itakura et al., 2014; Velikkakath et al., 2012), we 
employed a protease protection assay to determine whether TRAPPC11 depletion also 
affected this step of autophagy. This assay faithfully reports the state of the isolation 
membranes in both mammalian and lower eukaryotic systems (Klionsky et al., 2016; 
Velikkakath et al., 2012; Zhou et al., 2017). Following depletion, HeLa cells were either 
left in nutrient-rich medium or subjected to starvation for 2 hours in the presence of 
Bafilomycin A1, after which various membrane fractions were collected. The membranes 
were either untreated, treated with proteinase K, or solubilized in Triton X-100 before 
proteinase K treatment (Figure 2.3A). In control cells under nutrient-rich conditions, LC3 
(in the form of LC3-I) was mostly in the supernatant fraction (HS). Upon starvation, 
LC3-II was formed and largely found in the low-speed membrane fraction (LP). The 
protein in both the LP and the high-speed membrane fractions (HP) were resistant to 
proteinase K treatment but could be digested if the membranes were first solubilized with 
detergent, suggesting that autophagosomes were formed. In contrast, TRAPPC11-
depleted cells under nutrient-rich conditions showed LC3-II in both the LP and HP 
membrane fractions, consistent with the presence of abundant LC3-positive structures 
prior to starvation. These pools of LC3-II were sensitive to proteinase K in the absence of 
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detergent, suggesting that the LC3-II on the membranes is completely exposed to the 
surroundings. The same result was observed upon starvation of the TRAPPC11-depleted 
cells. The results in the TRAPPC11-depleted cells were similar to those seen for either 
ATG2- or WIPI4-depleted cells. In contrast, while LC3-II was detected both prior to and 
following starvation in TRAPPC12-depleted cells, this form of LC3 was resistant to 
proteinase K treatment in the absence of detergent, suggesting that autophagosome 
formation has occurred in the absence of TRAPPC12. In order to confirm that 
TRAPPC12 functions downstream of both ATG2 and TRAPPC11, the assay was 
performed following TRAPPC11/TRAPPC12 and ATG2/TRAPPC12 double depletions. 
In both cases, LC3-II was sensitive to proteinase K treatment in the absence of detergent 
(Figure 2.3B), supporting the notion that both ATG2 and TRAPPC11 function upstream 
of TRAPPC12. Consistent with the near complete absence of presumably LC3-II positive 
structures following TRAPPC8 depletion, only LC3-I was detected in this assay and this 
form of the protein did not fractionate in either of the membrane fractions (Figure 2.3A). 
This was phenotypically similar to what was seen for depletion of ATG9A (Figure 2.3A). 
Thus, although depletion of either TRAPPC11 or TRAPPC12 results in an increase in the 
number of LC3-positive cellular structures, only those formed in response to TRAPPC11 
depletion are unsealed membranes, similar to those seen upon ATG2 or WIPI4 depletion. 
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Figure 2.3 Depletion of TRAPPC11 results in unsealed isolation membranes. 
HeLa cells were treated with non-specific (NS) siRNA or siRNA targeting either of 
TRAPPC11, TRAPPC12, TRAPPC8, ATG2, WIPI4 or ATG9A. The cells were left in 
nutrient-rich medium (DMEM) or transferred to starvation medium (EBSS) for 2 hours in 
the presence of Bafilomycin A1. Lysates were prepared and processed for the membrane 
sealing assay as described in Materials and Methods. Prior to fractionation, some samples 
were treated with proteinase K (ProK) or with ProK in the presence of 1% Triton X-100. 
The fractions, composed of a postnuclear supernatant, low-speed pellet (LP), high-speed 
pellet (HP) and high-speed supernatant (HS), were probed for LC3. Note that isolation 
membranes and autophagosomes appear in the LP and/or HP fractions. Numbers to the 
right of the immunoblots denote the migration of molecular size standards in kD. (B) 
HeLa cells were depleted of both TRAPPC11 and TRAPPC12 or of ATG2 and 
TRAPPC12. The cells were starved for 2 hours in the presence of Bafilomycin A1. 
Lysates were prepared and processed as described in (A). 
 
2.4.4 Recruitment of ATG2B and WIPI4 to Isolation Membranes is Dependent 
Upon TRAPPC11 
 
We next investigated whether TRAPPC11 was required to recruit ATG2B and WIPI4 to 
membranes during starvation. The recruitment was first examined biochemically using 
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the cell fractionation assay performed in Figure 2.3. In this case, we probed for the 
presence of ATG2B, WIPI4, TRAPPC11, TRAPPC12 and TRAPPC8. We also included 
ATG9A and ATG12 as two autophagy proteins that function at different steps compared 
with TRAPPC11. ATG9A also served as a membrane protein control and in all cases 
where ATG9A was not the subject of the knockdown, the protein appeared exclusively in 
the membrane fractions as expected. The recruitment assay was performed in HeLa cells 
that were unstarved or starved for 2 hours in the presence of Bafilomycin A1. The cells 
were either untreated or depleted of either one of the TRAPP III proteins, ATG2, WIPI4 
or ATG9A (Figure 2.4). Upon depletion of TRAPPC11, less ATG2B and WIPI4 were 
found in the membrane fractions following starvation when compared with control. In 
contrast, TRAPPC12 depletion did not affect the membrane association of either ATG2B 
or WIPI4 following starvation compared with control. Neither TRAPPC11 nor 
TRAPPC12 depletion affected the recruitment of ATG12 to membranes. In contrast, 
while TRAPPC8 depletion also affected the recruitment of ATG2B and WIPI4 to 
membranes, this depletion prevented recruitment of ATG12 to membranes (Figure 2.4), 
likely due to the absence of isolation membranes. Although depletion of ATG2 prevented 
recruitment of WIPI4 to membranes, and WIPI4 depletion prevented recruitment of 
ATG2B to membranes, neither of depletion affected recruitment of any TRAPP III 
proteins or of ATG12 to membranes (Figure 2.4). As expected, and similar to the 
TRAPPC8-depleted cells, depletion of ATG9A prevented the recruitment of all proteins 
examined to membranes, consistent with its role in isolation membrane formation. 
 
We then assessed recruitment of ATG2B and WIPI4 to endogenous LC3 structures in 
HeLa cells depleted of either TRAPPC11, TRAPPC12 or TRAPPC8 (Figure 2.5A and 
B). Neither of ATG2B, WIPI4 nor LC3 localize to a substantial amount of punctae in 
control cells under nutrient-rich conditions. Upon starvation, these cells showed an 
increased number of LC3, ATG2B and WIPI4 structures, many of which overlap. As 
shown earlier in HeLa cells (Figure 2.1B and 2.2B), TRAPPC11 depletion resulted in a 
substantial number of LC3 punctae under nutrient-rich conditions and their numbers 
increased upon starvation. Importantly, we did not detect a concomitant increase in either 
of ATG2B or WIPI4 punctae in either nutrient-rich or starved conditions following 
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depletion of TRAPPC11 (Figure 2.5A and B). This was in contrast to the TRAPPC12-
depleted cells where, although there were numerous LC3 structures both prior to and 
during starvation, there were also numerous ATG2B and WIPI4 punctae co-localizing 
with LC3. Depletion of TRAPPC8 did not result in LC3-positive structures, nor in 
ATG2B or WIPI4 punctae, similar to what was seen upon ATG9A depletion (Figure 
2.5A and B). We conclude that the presence of ATG2B and WIPI4 on LC3-positive 
punctae in starved cells is dependent upon TRAPPC11 but not upon TRAPPC12. 
 
Figure 2.4 ATG2B-WIPI4 recruitment to membranes is impaired by TRAPPC11 
depletion. 
HeLa cells were treated with non-specific (NS) siRNA or siRNA targeting either 
TRAPPC11, TRAPPC12, TRAPPC8, ATG2, WIPI4 or ATG9A. Cells were grown in 
either nutrient-rich (DMEM) or starvation (EBSS) medium for 2 hours. Lysates were 
prepared and processed for membrane recruitment as described in the Materials and 
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Methods section. The fractions, composed of a postnuclear supernatant, low-speed pellet 
(LP), high-speed pellet (HP) and high-speed supernatant (HS), were probed for the 
indicated proteins. Note that half the amount of tubulin was loaded in the PN fraction in 
order to obtain an exposure that shows tubulin in the other fractions without grossly 
overexposing the PN signal. Numbers to the right of the immunoblots denote the 




Figure 2.5 Recruitment of ATG2B-WIPI4 to LC3-positive membranes is impaired 
by TRAPPC11 depletion 
(A) HeLa cells were treated with non-specific (NS) siRNA or siRNA targeting either 
TRAPPC11, TRAPPC12, TRAPPC8 or ATG9A. The cells were grown in nutrient rich 
(DMEM) or starvation (EBSS) medium for 2 hours at which time the cells were fixed and 
stained with anti-ATG2B or anti-WIPI4 IgG. (B) The LC3-positive and the ATG2B- or 
WIPI4-positive punctae in (A) were quantified using Imaris. A total of 25 cells were used 
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for quantification in each sample. Error bars represent SEM. The scale bar in (A) 
represents 20 µm. 
 
2.4.5 The TRAPPC11 Interaction with ATG2B-WIPI4 is Dependent Upon ATG9 
Function 
 
Our results thus far suggest that TRAPPC11 interacts with ATG2B-WIPI4, a complex 
that functions upstream of the sealing of isolation membranes into autophagosomes. 
Consistent with this notion is the fact that the consequences of TRAPPC11 depletion are 
phenotypically identical to that of either ATG2 or WIPI4 depletion. Suspecting that we 
might see an enhanced interaction between TRAPPC11 and ATG2B during starvation, 
we immunoprecipitated TRAPPC11 at various time points following starvation and 
probed for TRAPP proteins and ATG2B. As expected and reported previously (Bassik et 
al., 2013; Scrivens et al., 2011), TRAPPC11 co-immunoprecipitated with TRAPPC12, 
TRAPPC2 and TRAPPC8, but not with the TRAPP II subunit TRAPPC10 (Figure S2.3). 
Although an interaction with ATG2B was detected, we did not see a starvation-dependent 
increase in this interaction over time. Rather, there seemed to be a spike in the interaction 
at the 2-hour time point. The reason for this transient increase is not clear. In yeast, the 
TRAPP III complex was shown to interact with ATG9 (Kakuta et al., 2012). Another 
study demonstrated an interaction between yeast ATG2-ATG18 (the ATG2 and WIPI4 
homologs, respectively) with ATG9 (Gomez-Sanchez et al., 2018). These studies 
prompted us to examine whether the interaction between ATG2B-WIPI4 and mammalian 
TRAPP III also included ATG9A. As shown in Figure 2.6, immunoprecipitation of 
TRAPPC11 co-precipitated ATG2B and WIPI4, but not ATG9A. However, depletion of 
ATG9A abrogated the interaction between TRAPPC11 and both ATG2B and WIPI4. 
Furthermore, depletion of ATG2B prevented WIPI4 from co-immunoprecipitating with 
TRAPPC11. These results suggest that the TRAPPC11 interaction with ATG2B-WIPI4 is 
dependent upon ATG9A function and further show that TRAPPC11 does not interact 
with WIPI4 in the absence of ATG2B. 
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Figure 2.6 The interaction between TRAPPC11 and ATG2B-WIPI4 is regulated by 
ATG9A. 
HeLa cells were treated with non-specific (NS) siRNA or siRNA targeting either 
TRAPPC11, ATG9A or ATG2. The NS-treated samples were subjected to starvation to 
induce the formation of isolation membranes. Lysates were prepared and incubated with 
anti-TRAPPC11 IgG. The total lysates and the immunoprecipitates were probed by 
western analysis for the presence of TRAPPC11, ATG2B, WIPI4 and ATG9A. Numbers 
to the right of the immunoblots denote the migration of molecular size standards in kD. 
 
2.4.6 A Portion of TRAPP III Localizes to Isolation Membranes 
 
Our results thus far suggest that a portion of TRAPPC11, and perhaps TRAPP III, 
localizes to isolation membranes where it interacts with ATG2B-WIPI4. Autophagosome 
formation follows a maturation process where proteins function sequentially to produce 
these organelles. Two such proteins that are thought to associate with isolation 
membranes are ATG5 and WIPI1 (Grimmel et al., 2015). Thus, we used HeLa cells that 
express GFP-tagged versions of these proteins to assess their colocalization with TRAPP 
III proteins. Cells were either starved for 0.5 hours in the presence of Bafilomycin A1 to 
prevent autolysosome formation, or depleted of either ATG2 or WIPI4, conditions that 
lead to a buildup of isolation membranes (Figure 2.2B). The cells were then 
immunostained for either TRAPPC8, TRAPPC11 or TRAPPC12 and GFP. As shown in 
Figure 2.7A, ~10% to 15% of the ATG5 or WIPI1 punctae formed during brief starvation 
were also positive for the TRAPP III proteins. This percentage increased to ~20% to 25% 
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following depletion of either ATG2 or WIPI4. A similar increase in TRAPP protein co-
localization was seen using an LC3-GFP cell line (Figure S2.4). The co-localization is 
not likely incidental because (a) overlap was assessed using thin (0.4-1 µm) three-
dimensional sections and not flattened images, and (b) TRAPP protein-positive structures 
decreased in the ATG2 and WIPI4 knockdowns compared with starvation conditions (not 
shown) yet the co-localization increased during the knockdowns. These co-localization 
results suggest that a portion of TRAPP III proteins, including TRAPPC11, transiently 
localize to early autophagic membranes. Knowing that TRAPPC11 localizes to isolation 
membranes and is thus in proximity to ATG2B-WIPI4, we decided to more formally test 
the notion that the carboxy-terminus of TRAPPC11 is important for this interaction (see 
Table 2.3). To this end, we depleted HeLa cells of TRAPPC11 and assessed whether the 
defective recruitment of ATG2B and WIPI4 could be suppressed by expression of BirA-
C11 (a free carboxy-terminus) or C11-BirA (a blocked carboxy-terminus) using the same 
biochemical membrane recruitment assay as above (Figure 2.4). As shown in Figure 
2.7B, depletion of TRAPPC11 prevented the starvation-induced increase in membrane-
associated ATG2B and WIPI4 but not that of ATG12, an ATG protein acting at a step 
upstream of TRAPPC11. Overexpression of BirA-C11 resulted in an increase in 
membrane associated ATG2B and WIPI4 following starvation, while overexpression of 
C11-BirA resulted in a much smaller increase. The differences were not due to 
expression-level differences (Figure 2.7C). These results are consistent with the notion 
that the carboxy-terminus of TRAPPC11 is important for the recruitment of ATG2B-




Figure 2.7 A portion of TRAPP III localizes to isolation membranes. 
(A) HeLa cells stably expressing either ATG5-GFP or WIPI1-GFP were either starved 
for 30 minutes in EBSS containing Bafilomycin A1 or treated with siRNA targeting 
either ATG2 or WIPI4. The cells were then immunostained for one of the TRAPP III 
proteins (TRAPPC8, TRAPPC11 or TRAPPC12) and GFP. Representative images are 
		 51	
shown below the graph, with examples of co-localizing punctae indicated by a white 
arrowhead. The co-localization between TRAPP protein- and ATG5- or WIPI1-positive 
structures was quantified using Imaris and is plotted as the percentage of GFP-positive 
punctae that were positive for the indicated TRAPP III protein. A minimum of 10 cells 
were counted and the SEM is indicated. The scale bar represents 5 µm. In non-starved 
cells there were no visible ATG5-GFP or WIPI1-GFP punctae. (B) HeLa cells were 
depleted of TRAPPC11 using siRNA. The cells were then left untransfected or 
transfected with either BirA-C11 or C11-BirA. The cells were subsequently starved for 2 
hours in EBSS and the recruitment of ATG2B, WIPI4 or ATG12 to membranes was 
monitored as described in the Materials and Methods section. (C) Lysate from the non-
specific knockdown (lane 1), TRAPPC11 knockdown (lanes 2-4) either untransfected 
(lane 2) or transfected with either BirA-C11 (lane 3) or C11-BirA (lane 4) were probed 
with anti-TRAPPC11 antibody to assess expression levels of the BirA-tagged 
TRAPPC11 constructs. Numbers to the right of the immunoblots denote the migration of 
molecular size standards in kD. 
 
2.4.7 Fibroblasts from an Individual with TRAPPC11 Mutations Fail to Recruit 
ATG2B-WIPI4 to Membranes 
 
A number of individuals with TRAPPC11 mutations have now been reported 
(Bogershausen et al., 2013; Fee et al., 2017; Koehler et al., 2017; Larson et al., 2018; 
Liang et al., 2015; Matalonga et al., 2017). Because the carboxy-terminus of TRAPPC11 
appears to be important for ATG2B-WIPI4 recruitment to membranes (Figures 2.7C and 
Table 2.3), we examined the fibroblasts from one individual harboring the compound 
heterozygous mutations p.Ala372_Ser429del and p.Asp1127Valfs*47 in TRAPPC11 
(note that a more detailed characterization of this individual will be reported elsewhere) 
to determine if this newly-identified interaction was physiologically relevant. This 
individual was chosen because the latter allele results in a frame shift at amino acid 1127, 
only 6 residues from the carboxy-terminus. We first examined whether these cells 
displayed a defect in autophagic flux compared with control fibroblasts. Included in this 
analysis were fibroblasts from a patient with the homozygous p.Glu49Argfs*14 mutation 
in TRAPPC12 (Milev et al., 2017). Fibroblasts were untreated or starved for 2 hours in 
the presence of Bafilomycin A1, at which point they were returned to nutrient-rich 
medium and the appearance/disappearance of LC3-II was monitored. In control 
fibroblasts, the Bafilomycin A1-dependent increase in LC3-II levels was reverted to near 
unstarved levels following 40 minutes in nutrient-rich medium (Figure 2.8A). In contrast, 
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fibroblasts from the TRAPPC11 patient (PatC11) showed elevated levels of LC3-II prior 
to starvation that did not substantially increase after Bafilomycin A1 treatment. These 
elevated levels of LC3-II did not diminish upon transfer into nutrient-rich medium. The 
fibroblasts from the patient with the TRAPPC12 mutation (PatC12) showed a starvation-
induced increase in LC3-II levels that were slightly reduced upon transfer to nutrient-rich 
medium. These results suggest that both PatC11 and PatC12 have a defect in autophagic 
flux. We then examined the recruitment of ATG2B-WIPI4 by the biochemical 
fractionation procedure described above (Figure 2.3). While control fibroblasts showed a 
starvation-induced appearance of ATG2B and WIPI4 in the membrane fractions, PatC11 
cells did not (Figure 2.8B). In contrast, PatC12 cells showed ATG2B and WIPI4 in the 
membrane fraction even prior to starvation. Because reduced recruitment of ATG2B and 
WIPI4 to membranes could result in unsealed autophagosomes, we employed the 
protease protection assay to examine this scenario. While the LC3-II-positive membranes 
in control and PatC12 fibroblasts were largely resistant to proteinase K treatment, those 
in PatC11 were sensitive (Figure 2.8C). 
 
Finally, we examined the fibroblasts for recruitment of ATG2B and WIPI4 to punctae 
during starvation. Control fibroblasts showed a starvation-dependent increase in ATG2B 
and WIPI4 punctae (Figure 2.8D and Figure S2.5A). In contrast, PatC11 fibroblasts did 
not show such an increase, consistent with a role for TRAPPC11 in ATG2B-WIPI4 
recruitment. In PatC12, a large number of ATG2B- and WIPI4-positive punctae were 
present prior to starvation, suggesting that recruitment of ATG2B-WIPI4 was already 
taking place in these cells. The defect in starvation dependent ATG2B and WIPI4 
punctae formation in PatC11 was due to the TRAPPC11 mutations since this defect was 
suppressed by wild type TRAPPC11 fused at its amino-terminus, but not fused at its 
carboxy-terminus, to BirA (Figure 2.8E and Figure S 2.5B). This latter result is consistent 
with the earlier notion that the carboxy-terminus of TRAPPC11 is important for the 
recruitment of ATG2BWIPI4. Collectively, our studies on these fibroblasts from an 
individual with TRAPPC11 mutations suggest that some TRAPPC11 mutations may 
result in defective recruitment of ATG2B-WIPI4 and dysregulated autophagy. 
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Figure 2.8 Fibroblasts from an individual with TRAPPC11 mutations are defective 
in ATG2B-WIPI4 recruitment. 
(A) Control fibroblasts and fibroblasts derived from patients with bi-allelic TRAPPC12 
(PatC12) or TRAPPC11 (PatC11) mutations were transferred into starvation medium 
with or without Bafilomycin A1 for 2 hours. The Bafilomycin A1-treated cells were then 
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transferred into fresh nutrient-rich (DMEM) medium for up to 40 minutes. Lysates were 
prepared and LC3 and tubulin were detected by western analysis. A schematic of the 
treatment is shown above the graph. The inset shows a western analysis for TRAPPC11 
in all three cell lines. (B) The same fibroblasts as in (A) were grown in either nutrient rich 
(DMEM) or starvation (EBSS) medium for 2 hours. Lysates were prepared and processed 
for membrane recruitment detection by floatation as described in the Materials and 
Methods section. The indicated proteins were detected by western analysis. Note that half 
the amount of tubulin was loaded in the PN fraction in order to obtain an exposure that 
shows tubulin in the other fractions without grossly overexposing the PN signal. (C) The 
same fibroblasts as in (A) were grown in starvation (EBSS) medium for 2 hours in the 
presence of Bafilomycin A1. Lysates were prepared and processed for the membrane 
sealing assay as described in the Materials and Methods section. Prior to fractionation, 
some samples were treated with proteinase K (ProK) or with ProK in the presence of 1% 
Triton X-100. The fractions, composed of a postnuclear supernatant, low-speed pellet 
(LP), high-speed pellet (HP) and high-speed supernatant (HS), were probed for LC3. 
Note that the exposure for the PatC12 immunoblot is longer than for the others in order to 
reveal the LC3-II bands. (D) The same fibroblasts as in (A) were grown in nutrient-rich 
(DMEM) or starvation (EBSS) medium for 2 hours. The cells were then fixed and stained 
with anti-ATG2B or anti-WIPI4 antibody. The ATG2B (light gray bars) and WIPI4 (dark 
gray bars) punctae were quantified from a total of 25 cells for each condition. 
Representative images are shown in Figure S 2.5A. (E) Control (Ctrl) and PatC11 
fibroblasts were grown in nutrient-rich (DMEM) medium and left untransfected (Ctrl and 
PatC11) or PatC11 cells were transfected by electroporation with a construct expressing 
either BirA-C11 or C11-BirA as indicated. The cells were then fixed and stained with 
anti-ATG2B or anti-WIPI4 antibody. The ATG2B (light gray bars) and WIPI4 (dark gray 
bars) punctae were quantified from a total of 25 cells for each condition. Representative 
images are shown in Figure S2.5B. Numbers to the right of the immunoblots denote the 
migration of molecular size standards in kD.  
 
2.4.8 Depletion of TRAPPC11 and TRAPPC12 Also Affect Lysosomal Activity 
 
Both TRAPPC11 and TRAPPC12 function in membrane traffic (Scrivens et al., 2011) 
and one study implicated TRAPPC11 in lysosomal function (Bogershausen et al., 2013). 
While the autophagic flux defect resulting from TRAPPC11 depletion is due to unsealed 
autophagosomes, altered lysosomal proteolytic activity might explain the autophagic flux 
defect associated with TRAPPC12 depletion given that, in this case, sealed 
autophagosomes are forming (Figure 2.3A). We first assessed lysosomal proteolytic 
activity by examining the ability of HeLa cells depleted of either TRAPPC12, 
TRAPPC11 or ATG2 to process the lysosomal protease cathepsin B. Processing of this 
enzyme relies upon a proteolytically-active lysosome resulting in a cleaved, active, 
mature form (Hanewinkel et al., 1987). Depletion of either TRAPPC12 or TRAPPC11 
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resulted in greatly reduced levels of mature cathepsin B (Figure 2.9A). This may be due 
to a defect in trafficking of certain proteases, including cathepsin B, to the lysosome 
along the biosynthetic pathway (Scrivens et al., 2011; Wendler et al., 2010). In contrast, 
depletion of ATG2 did not result in a cathepsin B processing defect. We then more 
directly examined lysosomal proteolytic activity using the fluorogenic substrate DQ-
BSA. Upon delivery of DQ-BSA to the lysosomes, fluorescence is dequenched as a result 
of proteolytic activity (Mora et al., 2010). As shown in Figure 2.9B, depletion of either 
TRAPPC12 or TRAPPC11 resulted in much less fluorescence of DQ-BSA in the 
lysosome compared with control. This was again in contrast to ATG2 depletion, which 
showed strong DQ-BSA-dependent fluorescence. The DQ-BSA defect in TRAPPC11- or 
TRAPPC12-depleted cells was not because of an endocytic defect since uptake of a fluid-
phase marker in the absence of either protein was not affected (Figure S 2.6). This result 
supports the notion that both TRAPPC11 and TRAPPC12 affect lysosomal activity, 
likely due to a membrane trafficking defect in the biosynthetic pathway. If reduced 
proteolytic activity in lysosomes following TRAPPC12 depletion accounts for the 
autophagic flux defect (Figures 2.1 and 2.2), we would expect to observe an overlap 
between LC3 and the lysosomal marker LAMP1 following TRAPPC12 depletion, an 
indication that autolysosomes are indeed formed. As expected for unsealed membranes 
that form in response to depletion of either ATG2 or TRAPPC11, there was little overlap 
between the LC3-positive structures and LAMP1 (Figure 2.9C and D). Similarly, 
depletion of TRAPPC12 also resulted in low overlap between the LC3-positive structures 
and LAMP1, suggesting that the autophagic flux defect following TRAPPC12 depletion 
is upstream of autolysosome formation. Thus, although TRAPPC12 depletion results in 
lysosomes with reduced proteolytic activity, this does not account for the autophagic flux 
defect in these cells. Overall, our results indicate that during autophagy, ATG2 and 
TRAPPC11 function upstream of TRAPPC12. They further illustrate that TRAPPC11 
and TRAPPC12 also affect lysosome activity most likely through a defect in biosynthetic 
trafficking to the lysosome, although this second function does not account for the 
autophagic flux defect seen upon TRAPPC11 or TRAPPC12 depletion.  
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Figure 2.9 Lysosomal proteolytic activity is reduced upon depletion of either 
TRAPPC11 or TRAPPC12.  
(A) HeLa cells were treated with nonspecific (NS) siRNA, or siRNA targeting either 
TRAPPC11, TRAPPC12 or ATG2. Lysates were prepared and fractionated by SDS-
PAGE and then probed for cathepsin B. The mature (m) form of the enzyme is indicated. 
(B) The same cells in (A) were treated with DQ-BSA and lysotracker (LysoT), and 
processed for fluorescence microscopy as described in the Materials and Methods 
section. All images were obtained using the same exposure conditions. (C) The same 
cells as in (A) were fixed and stained for the lysosomal marker protein LAMP1 and for 
LC3. Co-localization between the two signals was determined using Imaris. 
Representative cells are displayed in (D). A minimum of 25 cells was used for the 
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quantification and the percentage of LAMP1 punctae that were also positive for LC3 is 
displayed. Numbers to the right of the immunoblots denote the migration of molecular 




Here, we have shown that depletion of three different TRAPP III associated proteins 
results in an autophagic flux defect suggesting a function in autophagy, but the specific 
steps in which these proteins function differ. Whereas TRAPPC8 affects formation of 
isolation membranes, TRAPPC11 is required upstream of the isolation membrane 
enclosure that leads to the formation of autophagosomes. TRAPPC12 acts downstream of 
TRAPPC11 after autophagosome formation. We also demonstrate that a fraction of each 
protein is associated with LC3-positive membranes suggesting that a portion of TRAPP 
III localizes to isolation membranes/autophagosomes. We examined the function of 
TRAPPC11 in more detail and found that it is required for recruitment of ATG2B-WIPI4.  
 
Combined with previous studies, we propose a model for the role of the TRAPPC11-
containing TRAPP III complex in isolation membrane formation and expansion (Figure 
2.10). Work in S. cerevisiae has shown that yeast TRAPP III interacts with ATG9-
containing vesicles (Kakuta et al., 2012). This interaction was mediated by Trs85, the 
yeast homologue of TRAPPC8. In the yeast system, initial recruitment of TRAPP III was 
ATG9-dependent. A functional link between mammalian ATG9A and TRAPPC8 was 
also demonstrated (Imai et al., 2016; Lamb et al., 2016). Thus, it is not unexpected that 
TRAPPC8 depletion would function upstream of isolation membrane formation and 
resemble an ATG9A depletion as we report here. Our model also suggests that 
recruitment of ATG2B-WIPI4 by TRAPPC11 serves several purposes. Previous work 
demonstrated that depletion of ATG2 resulted in unsealed membranes that did not fuse 
with lysosomes and it was suggested that ATG2 is required for isolation membrane 
elongation (Kishi-Itakura et al., 2014; Velikkakath et al., 2012). More recently, it has 
been suggested by both in vitro and in vivo studies that ATG2 can function as a tether 
during this process (Chowdhury et al., 2018; Gomez-Sanchez et al., 2018; Kotani et al., 
2018), prior to an ATG5-dependent sealing of the membranes into autophagosomes 
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(Kishi-Itakura et al., 2014). It has also been implied that WIPI4 regulates the association 
of ATG9A with LC3-containing membranes (Saitsu et al., 2013). Because ATG9A only 
associates transiently with LC3-membranes (Orsi et al., 2012), it is tempting to speculate 
that another consequence of the TRAPPC11-dependent recruitment of ATG2B-WIPI4 is 
the facilitation of the release of ATG9A from nascent isolation membranes/omegasomes.  
 
It is unclear at which step TRAPPC12 functions. Here, we have shown that 
autophagosomes are sealed following depletion of TRAPPC12 (Figure 2.3) and thus the 
protein functions downstream of TRAPPC11. The poor co-localization between LC3 and 
the lysosomal marker LAMP1 following TRAPPC12 depletion suggests that the role of 
TRAPPC12 in autophagy is prior to autolysosome formation. We can envision three 
possible functions for TRAPPC12 in this scenario. First, TRAPPC12 could recruit a late-
acting factor necessary for the fusion event, such as the putative interacting partner 
TECPR1 (Behrends et al., 2010), a protein previously implicated in autophagosome-
lysosome fusion (Chen et al., 2012). Second, it could be required to facilitate the activity 
of an as yet unidentified autophagosomal membrane protein necessary for formation of 
autolysosomes. Finally, it may be required as a second or supplemental tethering factor 
between autophagosomes and lysosomes. Although TRAPP complexes were first thought 
to act as tethers, a direct role in this process has yet to be shown. In addition, the HOPS 
complex has been suggested to mediate the tethering between autophagosomes and 
lysosomes (Jiang et al., 2014), so it is unclear if another tethering factor would be 
required. Further studies on TRAPPC12 will be required to determine its role in this late 
step of autophagy. 
 
Mutations in TRAPPC11 have been linked to disease (Sacher et al., 2019). The 
phenotypes are broad and include liver and eye involvement, achalasia, alacrima and 
intellectual deficit. However, virtually all individuals with TRAPPC11 mutations display 
some form of muscular pathology or an elevated creatine kinase level. Using fibroblasts 
derived from an individual with a compound heterozygous TRAPPC11 mutation, we 
have shown that they display a defect in autophagic flux likely due to impairment in 
ATG2B-WIPI4 recruitment to isolation membranes. With TRAPPC11 now linked to a 
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role in autophagy, there are three distinct cellular roles for this protein including lipid-
linked oligosaccharide synthesis and membrane traffic in the endomembrane system 
(DeRossi et al., 2016; Scrivens et al., 2011). It is unclear which dysregulated cellular 
process contributes to the clinical phenotype or whether it is a combination of all three.  
 
Indeed, both defective autophagy and glycosylation have been implicated in muscular 
dystrophies, particularly those caused by improper glycosylation of the protein 
dystroglycan (Michele et al., 2002; Sandri et al., 2013). Interestingly, one individual with 
a TRAPPC11 mutation was recently shown to have a dystroglycanopathy (Larson et al., 
2018). Furthermore, the glycosyltransferases essential for some of the modifications on 
dystroglycan are Golgi-resident enzymes that utilize the biosynthetic pathway to reach 
their destination (Grewal et al., 2005; Keramaris-Vrantsis et al., 2007; Matsumoto et al., 
2004; Yoshida et al., 2001). Further studies are required to tease apart the various 
functions of TRAPPC11 and their effects on muscle physiology.  
 
We also considered the possibility that the cellular phenotypes seen upon depletion of the 
TRAPP III proteins might be due to impaired guanine nucleotide exchange factor (GEF) 
activity for RAB1 because this GTPase has been implicated in autophagosome biogenesis 
(Zoppino et al., 2010). In yeast, it is known that TRAPP III acts as a GEF for the RAB1 
homologue Ypt1 (Thomas et al., 2018), and that Ypt1 is important for recruitment of both 
ATG1, the functional homologue of mammalian ULK1, and ATG11 (Lipatova et al., 
2012; Wang et al., 2013). In higher eukaryotes, only TRAPP II, and not TRAPP III, was 
reported to act as a GEF for RAB1 (Li et al., 2017; Yamasaki et al., 2009). Thus, it 
seemed unlikely that depletion of TRAPP III proteins would affect GEF activity for 
RAB1. Nevertheless, we examined whether a dominant-negative form of RAB1 could 
phenocopy a TRAPPC11 depletion, and whether a constitutively-active form of RAB1 
could suppress the phenotype resulting from TRAPPC11 depletion. Neither was observed 
(not shown) suggesting that the phenotypes seen upon depletion of TRAPP III proteins 
are not because of an effect on the activity of RAB1.  
 
Several pieces of evidence implicate the carboxy-terminus of TRAPPC11 in the 
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recruitment of the ATG2B-WIPI4 complex. First, of the TRAPPC11 mutations in the 
compound heterozygous individual examined in this study, one allele 
(p.Asp1127Valfs*47) has a frame shift mutation starting six amino acids from the 
carboxy-terminus of this 1133 amino acid-long protein. The second allele 
(p.Ala372_Ser429del) results in an unstable protein (Bogershausen et al., 2013). Because 
a reduced level of TRAPPC11 is detected in the cell lysate from these fibroblasts, it is 
likely to be due to the p.Asp1127Valfs*47 variant. Given that ATG2B-WIPI4 is not 
recruited to membranes in these cells, a role for the carboxy-terminus in ATG2B-WIPI4 
recruitment could be inferred. The BioID results are also consistent with this notion. In 
this case, biotinylation of both ATG2B and WIPI4 was more efficient using BirA-C11 
(free-carboxy-terminus) compared to C11-BirA. This was not due to an expression-level 
difference because expression levels of the BirA constructs were essentially the same (not 
shown). The specific affinity is in addition supported by the fact that C11-BirA showed 
preference for some other proteins compared to BirA-C11 (eg, TRAPPC8 and 
TRAPPC13).  
 
Finally, we demonstrate better recruitment of ATG2B and WIPI4 to membranes with 
BirA-C11 compared to C11-BirA in both HeLa and fibroblast cells. Our study not only 
implicates TRAPP III proteins in autophagy, but it provides evidence that TRAPPC11 
and TRAPPC12 are also required for proper proteolytic function of the lysosome. This is 
likely due to their role in biosynthetic membrane trafficking (Scrivens et al., 2011; 
Wendler et al., 2010). While it is possible that altered lysosomal activity could affect 
formation of autolysosomes (Seranova et al., 2017), we do not favor this possibility for 
several reasons. In the case of TRAPPC11 depletion, the autophagic flux defect is caused 
by the resulting unsealed isolation membranes because sealed membranes are required 
for autolysosome formation (Kishi-Itakura et al., 2014). This notion is further supported 
by the ATG2 knockdown that showed normal lysosomal activity with respect to 
cathepsin B and DQ-BSA (Figures 2.9 A and B), yet these unsealed structures did not 
fuse with the lysosomes (Figure 2.9 C and D). Thus, there appears to be no correlation 
between lysosomal proteolytic activity and isolation membrane sealing. In the case of 
TRAPPC12 depletion, there was poor co-localization between the lysosomal marker 
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LAMP1 and LC3, suggesting that its functions in biosynthetic membrane traffic and 
autophagy are probably unrelated, although this will require more experimentation to 
better clarify. 
 
The precise function of ATG2 in autophagosome formation and its recruitment to 
membranes is unclear, but recent studies suggest it may function in isolation membrane 
expansion. An ultrastructural study on mouse and human cells indicated that upon 
depletion of ATG2, isolation membranes failed to expand (Kishi-Itakura et al., 2014). 
Some of the structures in the ATG2-depleted cells appeared circular in shape. However, 
because circular structures were not seen in ATG2A/ATG2B double knockout cells 
(Tamura et al., 2017), such structures in the depleted cells probably resulted from an 
incomplete inactivation of the protein. Indeed, only small membranes were seen in the 
absence of both ATG2 proteins, supporting the notion that ATG2 is required for isolation 
membrane elongation. Recent studies demonstrated an in vitro tethering ability for 
ATG2A (Chowdhury et al., 2018) (Kotani et al., 2018), consistent with its role in 
membrane elongation. While the extreme amino-terminus of ATG2 is required for 
isolation membrane binding in vivo (Tamura et al., 2017), the interactions that regulate 
its membrane association are unclear. Because WIPI proteins are recruited to PI(3)P-
containing membranes (Grimmel et al., 2015), and WIPI4 interacts with ATG2, WIPI4 is 
thought to recruit ATG2 to such membranes that form after starvation. However, this 
complex still interacts in vitro with artificial liposomes devoid of PI(3)P (Zheng et al., 
2017) (Chowdhury et al., 2018; Kotani et al., 2018). Thus, the recruitment of ATG2 in 
vivo may in fact be regulated by a number of different factors, and we propose that 
TRAPPC11 is one such factor. 
 
Our present study places TRAPPC11 upstream of ATG2B, prior to the ATG5-dependent 
sealing of isolation membranes. Furthermore, our study implicates ATG2B-WIPI4 
recruitment to isolation membranes as critical for human health. Indeed, the function of 
WIPI4 has also been implicated in human health (Saitsu et al., 2013) (Haack et al., 2012). 
Future studies will be aimed at characterizing the membranes that form in the absence of 
TRAPPC11 in both HeLa cells and primary fibroblasts derived from individuals with 
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TRAPPC11 mutations at the ultrastructural level, as well as detailing the distinct roles of 
each TRAPP III subunit in the formation of isolation membranes. 
 
Figure 2.10 A model for the role of TRAPP proteins in autophagy. 
The model depicts the various stages of autophagy and which stage is affected by the 
TRAPP III proteins. The green arrows indicate that the TRAPP protein influences that 
particular step. The dark line connecting TRAPPC11 to ATG2B is based on the BioID 
result (Table 2.3). See text for details. 
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2.6 Supporting information 
 
Figure S2.1 (Related to Figure 2.1) 
(A) HeLa cells stably expressing mRFP‐GFP‐LC3 were transfected with siRNAs 
targeting the indicated genes. Lysates were fractionated by SDS‐PAGE and probed for 
the indicated proteins by western blotting. (B) HeLa cells stably expressing mRFP‐GFP‐
LC3 were left untreated or treated with siRNA targeting TRAPPC11 or TRAPPC12. The 
cells were then transferred to starvation (Earle's Balanced Salt Solution [EBSS]) medium 
for 1 hour. At that time, the live cells were imaged every 20 seconds for 10 minutes. 
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Individual GFP‐positive punctae (N = 25‐40 in different cells) were followed and the 
fluorescence intensity was measured at time t = 0 and again at time t = 120 seconds. The 
percent GFP intensity (100 × [intensityt = 120 seconds/intensityt = 0 secods]) was plotted vs the 
percentage of punctae displaying that intensity. Representative individual GFP‐LC3 
punctae in live cells over the course of the 120‐second time‐frame are shown. Note the 
decrease in GFP fluorescence, but not RFP fluorescence, for untreated HeLa cells 
indicating fusion between autophagosomes and lysosomes. A similar decrease in GFP 
fluorescence is not seen for TRAPPC11‐ and TRAPPC12‐depleted cells. (C) HeLa cells 
stably expressing mRFP‐GFP‐LC3 were transfected with siRNAs targeting either 
TRAPPC11 or TRAPPC12. GFP‐positive punctae were measured in Imaris following 
deconvolution of the images in AutoQuant. N values are 77 (NS KD), 80 (C12 KD) and 
127 (C11 KD). The mean diameter is shown as a black horizontal line. Numbers to the 




Figure S2.2 (Related to Figure 2.2) 
Quantification of the western blot in Figure 2A was performed This blot and the bar 








Figure S2.3 (Related to Figure 2.6) 
HeLa cells were treated with siRNA targeting either TRAPPC11 or ATG2. The cells 
were then transferred into starvation medium and lysates were prepared at the times 
indicated in hours. A portion of the samples was treated with anti‐TRAPPC11 antibody. 
The indicated proteins were detected by western analysis. Numbers to the right of the 




Figure S2.4 (Related to Figure 2.7) 
(A) HeLa cells were untreated or treated with siRNA targeting either ATG2 or WIPI4. 
The untreated cells were either left in nutrient‐rich medium (DMEM) or starved for 2 
hours (EBSS) in the presence of 200 nM Bafilomycin A1. The cells were then stained for 
one of the TRAPP III proteins (TRAPPC8, TRAPPC11 or TRAPPC12) and LC3. 
Representative images are shown in (B). The co‐localization between TRAPP protein‐ 
and LC3‐positive structures was quantified using Imaris and is plotted as the percentage 
of LC3‐positive punctae that were positive for the indicated TRAPP III protein. A total of 
		 67	
15 cells were counted and the SEM is indicated. The scale bar represents 20 µm. 
Significance was assessed using a one way ANOVA with a post hoc Fisher's protected 
least squares difference using SPSS version 24. Asterisks indicate increases whose p 
values are less than 0.05 relative to the corresponding non‐starved controls. 
 
Figure S2.5 (Related to Figure 2.7)  
(A) Fibroblasts from control, PatC11 and PatC12 were unstarved (DMEM) or starved for 
2 hours (EBSS). The cells were then fixed and stained for ATG2B or WIPI4. The images 
are representative images used for the quantification in Figure 8D. (B) The same cells as 
in (A) were electroporated with a construct expressing either BirA‐C11 or C11‐BirA as 
indicated. Transfected cells were identified by anti‐FLAG antibody. The cells were 
stained for either ATG2B or WIPI4. Quantification in Figure 2.8E was performed on 




Figure S2.6 (Related to Figure 2.9) 
HeLa cells were untreated or depleted of either TRAPPC11, TRAPPC12 or ATG2. The 
cells were then incubated with the fluid‐phase marker pHrodo Red and Lysotracker 
Green to assess endocytosis. Images were obtained 20 minutes after addition of the 




Chapter 3: Characterization of Three TRAPPC11 Variants Suggests a Critical Role 
for the Extreme Carboxy-terminus of the Protein 
 
This Chapter was published as a manuscript in the journal (Milev et al., 2019) I shared 
first authorship of this paper with Miroslav Milev and I am responsible for the following 
figures: Figure 3.4a and Figure 3.6 (a, b, c, d, e), while Dr. Milev is responsible for the 
figures: Figure 3.4b and c and Figure 3.5. The q-PCR analysis was done by Dr. Saint-Dic 




TRAPPC11 was identified as a component of the TRAPP III complex that functions in 
membrane trafficking and autophagy. Variants in TRAPPC11 have been reported to be 
associated with a broad spectrum of phenotypes but all affected individuals display 
muscular pathology. Identifying additional variants will further our understanding of the 
clinical spectrum of phenotypes and will reveal regions of the protein critical for its 
functions. Here we report three individuals from unrelated families that have bi-allellic 
TRAPPC11 variants. Subject 1 harbors a compound heterozygous variant (c.1287+5G>A 
and c.3379_3380insT). The former variant results in a partial deletion of the foie gras 
domain (p.Ala372_Ser429del), while the latter variant results in a frame-shift and 
extension at the carboxy terminus (p.Asp1127Valfs*47). Subjects 2 and 3 both harbour a 
homozygous missense variant (c.2938G>A; p.Gly980Arg). Fibroblasts from all three 
subjects displayed membrane trafficking defects manifested as delayed endoplasmic 
reticulum (ER)-to-Golgi transport and/or a delay in protein exit from the Golgi. All three 
individuals also show a defect in glycosylation of an ER-resident glycoprotein. However, 
only the compound heterozygous subject displayed an autophagic flux defect. 
Collectively, our characterization of these individuals with bi-allelic TRAPPC11 variants 





The transport protein particle complexes are a family of related multisubunit protein 
complexes that share a core of subunits and contain complex-specific proteins that impart 
their differing functions. The TRAPPC11 protein was initially identified as a component 
that associates with the TRAPP III complex (Scrivens et al., 2011; Wendler et al., 2010). 
This complex was originally reported to play an as yet undefined role in membrane 
trafficking in the biosynthetic pathway. More recently, a role for the TRAPP III-specific 
subunits in autophagy was proposed (Behrends et al., 2010; Lamb et al., 2016; Ramirez-
Peinado et al., 2017; Stanga et al., 2019). Specifically, the TRAPPC11 protein of this 
complex was shown to function upstream of autophagosome sealing, while TRAPPC12 
functions prior to autophagosome-lysosome fusion (Stanga et al., 2019). Although the 
yeast TRAPP III complex has been implicated as a guanine nucleotide exchange factor 
(GEF) for Ypt1 (Jones et al., 2000; Thomas et al., 2018; Wang et al., 2018), the RAB 
target of the human TRAPP III complex is still unclear. Interestingly, Drosophila TRAPP 
III was shown to be capable of nucleotide exchange on RAB1 (Riedel et al., 2018). 
Whether all of the proteins of the TRAPP III complex function independently in other 
cellular processes is still unclear but two subunits, TRAPPC11 and TRAPPC12, appear to 
function in N-linked glycosylation (TRAPPC11), and mitosis and recruitment of the COP 
II coat (TRAPPC12) to the exclusion of other TRAPP III proteins (DeRossi et al., 2016; 
Milev et al., 2015; Zhao et al., 2017). Thus, elucidating the roles of TRAPP III proteins 
both within and outside of the complex is important to better understand their cellular 
functions. In the case of TRAPPC11 and other TRAPP proteins, it is possible that regions 
or domains of the protein may play a role in different cellular pathways. 
 
To date, a number of variants in the genes encoding TRAPP proteins have been described 
(Sacher et al., 2019). While variants in a core subunit called TRAPPC2 exclusively result 
in a skeletal defect, those in TRAPPC11 result in neuromuscular defects as well as a 
broad spectrum of other clinical features including scoliosis, alacrima, steatosis, 
intellectual deficit and cerebral atrophy (Bogershausen et al., 2013; Fee et al., 2017; 
Koehler et al., 2017; Larson et al., 2018; Liang et al., 2015; Matalonga et al., 2017; Wang 
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et al., 2018). This may be due to the various processes that are impacted by TRAPPC11 
within the cell. 
 
The domain structure of TRAPPC11 indicates several regions that may be involved in 
either protein-protein interactions or may be important for its function. For example, a 
region spanning amino acids 263-561, referred to as the foie gras domain, is well-
conserved through evolution, suggesting a critical function for this domain. Variants 
within this domain have been reported including an in-frame deletion (Bogershausen et 
al., 2013; Larson et al., 2018; Matalonga et al., 2017; Wang et al., 2018), further 
highlighting the importance of this region. In addition, a well-conserved 60-amino acid 
stretch near the carboxy terminus referred to as the gryzun domain has also been noted, 
although its functional significance remains unknown. Most studies on TRAPPC11 
variants have assessed membrane trafficking defects and Golgi morphology and found 
either one or both to be defective (reviewed in (Sacher et al., 2019)). 
 
The mapping of natural variants in a protein is useful in elucidating its function and 
allowing clinicians and researchers to better predict the cellular consequences of new 
variants. In the case of TRAPP proteins, a missense variant in TRAPPC2 that changes 
aspartate 47 to tyrosine was shown to affect the interaction between TRAPPC2 and both 
TRAPPC8 and TRAPPC9 (Brunet et al., 2013; Zong et al., 2011). A similar missense 
variant in TRAPPC2L results in elevated levels of the active form of the GTPase RAB11 
(Milev et al., 2018). In other instances, such as for described variants in TRAPPC9 
(Sacher et al., 2019), it remains unclear how they affect the function of the protein. Thus, 
identifying new variants and individuals with previously-described variants will further 
our understanding of the importance of specific regions of TRAPP proteins. 
 
Here, we describe three individuals with either compound heterozygous or homozygous 
variants in TRAPPC11. All three individuals have variants at or near the carboxy-
terminus of the protein. The compound heterozygous individual also has an in-frame 
deletion in a highly-conserved central region of the protein that was previously reported 
(Bogershausen et al., 2013). The purpose of this study was to analyze in detail the effects 
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of these genetic defects on protein function. The clinical and cell biological features for 
each individual support the notion that the carboxy-terminus of the protein is critical for 
biological function. 
 
3.3 Materials and Methods 
 
This study was carried out in accordance with the Declaration of Helsinki. Written 
informed consent was obtained from patients and/or their parents or guardians. All 
experimental protocols were approved by the ethical committee of the Medical Faculty of 
the University of Giessen, Germany, and by the Comitè d'Ètica d'Investigació Clínica 
(CEIC) de la Fundació Sant Joan de Déu (Fundacion Sant Joan de Déu Ethics Committee 
on Clinical Research (CEIC)). Methods were carried out in accordance with the relevant 
guidelines and regulations. 
 
3.3.1 Molecular Genetics 
 
Whole exome sequencing, data processing and analysis were performed as previously 




Open muscle biopsies were taken from the lateral vastus muscles (S1, S2 and S3) or the 
deltoid muscle (S1), oriented and frozen according to standard procedures. Frozen 
sections (10 µm for S1 and 6 µm for S2 and S3 for histology and histochemistry, and 7 
µm for immunohistochemistry) were examined using routine histological and 
histochemical stains including haematoxylin and eosin (HE) and modified Gomori 
trichrome and cytochrome oxidase (COX/SDH) (Dubowitz et al., 2014). 
Immunohistochemical analysis was performed using a Bench Mark XT automatic 
staining platform (Ventana, Heidelberg, Germany; Ultraview Universal DAB Detection 
kit) with the following primary antibodies: anti-MHC neonatal, anti-MHC slow, anti-
Myotilin and anti-α-dystroglycan. The sections were examined on a Nikon Eclipse 80i 
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microscope equipped with a CCD camera. For transmission electron microscopy (TEM) 
in S2 and S3, small biopsies were fixed in 6% glutaraldehyde/0.4 M phosphate buffered 
saline (PBS) and were processed with a Leica EM TP tissue processor. Ultrathin sections 
were contrasted with 3% lead citrate-3H20 with a Leica EM AC20 (ultrastain kit II) and 
examined on a Zeiss EM109 TEM equipped with a sharp eye digital camera. 
 
3.3.3 Membrane Trafficking Assays 
 
Fibroblasts were maintained in DMEM supplemented with 10% fetal bovine serum. In 
order to examine ER-to-Golgi trafficking, the RUSH assay was performed (Boncompain 
et al., 2012) and quantified as previously described (Milev et al., 2017). Trafficking of 
VSVG-GFP ts045 was performed following viral infection of the construct and 
quantified as previously described (Koehler et al., 2017). 
 
3.3.4 Autophagy Assays 
 
Assessment of autophagosome formation by susceptibility to proteinase K was performed 
essentially as described (Velikkakath et al., 2012) with minor modifications (Stanga et 
al., 2019). For assessment of autophagic flux the cells were washed with phosphate-
buffered saline (PBS) and incubated with Earle’s Balanced Salt Solution (EBSS; Wisent, 
St. Bruno, Canada) for the times indicated in the figure. In some cases, 200 nM 
Bafilomycin A1 (Sigma-Aldrich) was included during a 2-hour starvation. The starved 
cells were returned to nutrient-rich medium by washing with PBS and incubating in 
DMEM with 10% FBS for 20 or 40 minutes. The cells were lysed by harvesting in lysis 
buffer (150 mM NaCl, 50 mM Tris pH 7.2, 1 mM DTT, 1% Triton X-100, 0.5 mM 
EDTA, Complete protease inhibitors (Roche, Basel, Switzerland)) and analyzed by 
western blotting for LC3 (abcam, Cambridge, MA). The data were normalized to the 







Primary antibodies used in this study were Rabbit anti-LC3 (abcam, Cambridge, MA), 
mouse anti-LC3 (Santa Cruz, Dallas, TX), Rabbit anti-LAMP1 (abcam, Cambridge, 
MA), Rabbit anti-TRAPPC11 (Sacher laboratory), mouse anti-tubulin (Sigma-Aldrich, 
St. Louis, MO), Rabbit anti-mannosidase II (gift from Dr. Kelly Moreman), mouse anti-
TRAP-α (Santa Cruz, Dallas, TX), mouse anti-FLAG (Sigma-Aldrich, St. Louis, MO), 
anti-neonatal myosin heavy chain (NCL-MHCn;, Leica Biosystems, Wetzlar, Germany), 
anti-MHC neonatal (Novocastra/Leica Biosystems, Wetzlar, Germany) anti-MHC 
slow  (Novocastra/Leica Biosystems, Wetzlar, Germany) anti-myotilin (Novocastra/ 
Leica Biosystems, Wetzlar, Germany), and anti-alpha-dystroglycan  (Merck-Millipore, 
Burlington, MA).  Secondary antibodies used in this study were anti-mouse 
Alexafluor488 and anti-Rabbit Alexafluor647 (Life Technologies, Carlsbad, CA). Note 
that for all western blots displayed, the membranes were cut in the region where the 
protein migrates in order to maximize the number of proteins that could be analyzed on 
each blot. 
 
3.3.6 Fluorescence Microscopy 
 
The cells were washed with PBS, fixed with 4% paraformaldehyde for 20 minutes at 
room temperature, quenched with 0.1 M glycine for 10 minutes and permeabilized with 
0.1% Triton X-100 for 8 minutes. Blocking was performed in 5% normal goat serum in 
PBS for 30 minutes at room temperature. Primary antibodies were diluted in 5% normal 
goat serum and were added to coverslips and incubated overnight at 4°C. Cells were 
washed two times 10 minutes with PBS. Secondary antibodies were diluted in 5% normal 
goat serum in PBS and applied for 1 hour at room temperature. The coverslips were 
washed several times with PBS with Hoescht being added during the first wash. The 
coverslips were then mounted with Prolong Gold AntiFade (Life Technologies, Carlsbad, 
CA) and sealed with nail polish. Images were recorded on an Olympus FV10i microscope 
fitted with a 60X objective, NA 1.35. The images were acquired with 0.25 µm increment 
size, deconvolved in AutoQuant (Media Cybernetics, Rockville, MD) and quantified with 
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Imaris (Bitplane, Concord, MA). For colocalization of LC3 and LAMP1, a total of 10 
cells were analyzed for each condition. 
 
3.3.7 Quantitative PCR 
 
Messenger RNA (mRNA) was harvested from cells using the Quick-RNA Miniprep kit 
(Zymo Research, Irvine, CA) according to the manufacturer’s instructions. A total of 1 
µg of mRNA was subjected to first strand synthesis using MMuLV reverse transcriptase 
(New England Biolabs, Ipswich, MA). Polymerase chain reactions were then set up in 
triplicate using iTaq™ Universal SYBR® Green Supermix (Bio-Rad Laboratories, 
Hercules, CA). Samples were subjected to thermal cycling and detection of the 
fluorescent signal in a Bio-Rad CFX96 real-time PCR detection system. Quantification 
was performed by the ΔΔCT method.  
Oligonucleotides used were:  
ATF6-F 5’ CAGACAGTACCAACGCTTATGCC-3’;  
ATF6-R 5’ GCAGAACTCCAGGTGCTTGAAG-3’;  
XBP1-F 5’-CTGCCAGAGATCGAAAGAAGGC-3’;  
XBP1-R 5’-CTCCTGGTTCTCAACTACAAGGC-3’;  
DDIT3-F 5’-GGTATGAGGACCTGCAAGAGGT-3’;  
DDIT3-R 5’-CTTGTGACCTCTGCTGGTTCTG-3’; 
BIP-F 5’-CTGTCCAGGCTGGTGTGCTCT-3’;  
BIP-R 5’-CTTGGTAGGCACCACTGTGTTC-3’;  
DNAJC3-F 5’-GGAGAGGATTTGCCACTGCTTTT-3’;  
DNAJC3-R 5’-CTCTGCTCGATCTTTCAGGGCA-3’;  
EDEM1-F 5’-ACGAGCAGTGAAAGCCCTTTGG-3’;  
EDEM1-R 5’-CCACTCTGCTTTCCAACCCAGT-3’;  
ATF4-F 5’-TTCTCCAGCGACAAGGCTAAGG-3’;  
ATF4-R 5’-CTCCAACATCCAATCTGTCCCG-3’;  
ActB-F 5’-CACCATTGGCAATGAGCGGTTC-3’; 




3.4.1 Clinical Summary and Molecular Genetics 
 
Subject S1 is a male infant born at 37 weeks of gestation. He was the first child of a 
healthy, young Caucasian couple. The family history was unremarkable with no similarly 
affected individuals, consanguinity, birth defects, or miscarriages. The pregnancy history 
was normal. The infant’s birth weight was 2948 g, length was 48 cm, and head 
circumference was 31.5 cm, all within the standard range (10th–90th centiles) for male 
Spanish neonates. Developmental delay was noted since head control was not acquired 
until 4 months old. The subject presented with a febrile status at five months old. 
Hypotonia, spasticity, and abnormal involuntary movements, including hyperkinesia and 
choreiform movements, appeared during the first year of life. Ability to sit, stand, or say 
words was never acquired. Cerebral atrophy and reduced white matter volume were 
observed from the first magnetic resonance imaging study (Figure 3.1A). Serum creatine 
kinase (CK) levels were persistently elevated, ranging from 350 to 2817 IU/l (normal 
value < 190 IU/l). Muscle biopsy was performed at the age of 4 years and showed 
minimal myopathic changes consisting of mild variation in muscle fibre diameter, a 
population of fibres with weak cytochrome c activity and a few fibres of normal size 
positive for neonatal myosin indicating fiber regeneration (Figure 3.1B). Intracellular 
lipids and glycogen were within normal limits. Immunohistochemistry for sarcolemmal 
proteins was normal. Alpha-dystroglycan glycosylation by means of immunofluorescence 
(clone IIH6 and VIA4-1) and immunoblot (IIH6) was not significantly reduced compared 
to the normal control analysed in parallel (not shown). 
 
On recent assessment the subject was 9 years old. His height was 121 cm (centile <1, -
2.45 SD), weight was 21.3 kg (centile 6, -1.58 SD) and head circumference was 44.5 cm 
(centile <1,-6.5 SD). Poor eye contact, axial hypotonia, spasticity, and choreiform 
movements persisted. He was unable to sit independently. A remarkable cerebral atrophy 
remained in successive magnetic resonance studies. There was no evidence of any 
clinical seizure since the febrile status. Successive EEGs did not register electrical 
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seizures or epileptiform activity. Antiepileptic treatment with valproic acid was initiated 
after the first febrile status at 5 months and stopped at the age of 4 years (Table 3.2). 
Because of global hypotonia and elevated CK, the subject was included in the MYO-SEQ 
project (undiagnosed myopathies/limb girdle muscular dystrophies with elevated CK). 
Whole exome sequencing revealed that S1 harbours two heterozygous variants in 
TRAPPC11. The first is an extended splice site variant, c.1287+5G>A (GRCh37/hg19 
chr4:184605212), that is rare in both the Genome Aggregation Database (gnomAD) and 
in the Exome Aggregation Consortium (ExAC) database control population (0.005% and 
0.002%, respectively, with no homozygotes) and has a CADD PHRED score (Rentzsch 
et al., 2019) of 15.64 (Table 3.1). The variant, which results in a 58 amino acid in-frame 
deletion (p.Ala372_Ser429del), has been previously reported in homozygosity to be 
associated with myopathy, infantile hyperkinetic movements, ataxia and intellectual 
disability in five individuals of Hutterite descent (Bogershausen et al., 2013). The second 
variant results in a frameshift, c.3379_3380insT (GRCh37/hg19 chr4:184633774), that is 
absent in both the gnomAD and ExAC control population, with a CADD PHRED score 
of 35.0, and results in a protein change of p.Asp1127Valfs*47 (Table 3.1). Both variants 
were confirmed by Sanger sequencing and were inherited each from one of the 
unaffected parents (Figure 3.1C). 
 
 
Table 3.1 TRAPPC11 variants and frequency for the newly-reported alleles 
 
subject Variant allele frequency CADD 
v1.3 
















S3 NM_021942.5:c.2938G>A; p.Gly980Arg 
 
The PHRED-like scaled C-score ranks a genetic variant relative to all possible 
substitutions of the human genome. A scaled C-score of 20 or greater indicates that the 
variant is amongst the 1% most deleterious substitutions (Rentzsch et al., 2019). 
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Subject S2 is the fourth of six children of healthy consanguineous Turkish parents. The 
girl was born at 26 weeks gestational age due to preterm premature rupture of membranes 
and amnion infection syndrome. Birth weight was 1000 g, length was 35 cm, and head 
circumference was 25 cm (10th-50th centiles). The perinatal period was complicated by 
hyperbilirubinemia, pneumonia, and respiratory distress syndrome, and the subject had to 
be ventilated for 28 days. Muscular hypotonia and elevated CK values prompted a muscle 
biopsy at age 9 months that showed myopathic alterations. Her early motor development 
was delayed, and she achieved walking without support at age 3 years. At age 8 years, the 
subject was hospitalized due to pneumonia. At that age, weight was 15 kg (centile<1, -3.2 
SD), length was 122 cm (10th centile), and head circumference was 46 cm (centile<1, -3.1 
SD). She presented with marked muscle atrophy, had difficulties when standing up from 
the ground (Gowers sign), and showed a waddling gait, hyperlordosis, and scoliosis. A 
second muscle biopsy showed features of a congenital myopathy with type 1 fiber 
predominance and focal Z-band abnormalities at the ultrastructural analyses (Figure 3.2). 
Neuropsychological testing disclosed a learning disability (IQ 75). She had normal 
aspartate aminotransferase (GOT) values, but elevated alanine aminotransferase (GPT) 
values (maximum 118 U/l, normal range <35). Her CK was elevated with values up to 
500-1500 U/l. While albumin and coagulation parameters were within the normal range, 
cholinesterase values were reduced (minimum 606 U/l, normal range of 4000-12000). 
Moreover, amylase and lipase values were slightly elevated on several occasions without 
any clinical signs of pancreatic dysfunction. Echocardiography showed no signs of 




Figure 3.1 Brain and muscle abnormalities in subject S1 at age 4 years. 
(A) Brain magnetic resonance imaging of the individual at the age of 3. Note cortical 
atrophy and reduced white matter volume in both coronal T2-weighted (left panel) and 
axial T1-weighted (right panel) images. (B) Muscle biopsy was performed at the age of 4 
years and showed minimal myopathic changes consisting of mild variation in muscle 
fibre diameter (i, ii), a population of fibres with weak cytochrome c activity (iii) and a 




Figure 3.2 Muscle abnormalities in subject S2 at age eight years. 
H&E stained sections show muscle fibers with increased variation of diameter and few 
fibers with internalized nuclei (arrows) (i). In the COX/SDH staining some fibers show 
subsarcolemmal mitochondrial aggregates (arrows) (ii). MHC-neonatal expression in few 
fibers indicates regenerative muscle fiber (iii). Staining with MHC slow antibodies shows 
type1 fiber predominance (iv). Antibodies against myotilin display a few fibers with 
subtle myofibrillar disintegration (arrow) (v). Sarcolemmal α-dystroglycan expression is 
reduced in a few fibers (arrow) (vi). Ultrastructural analysis shows that the sarcolemma is 
focally folded with subsarcolemmal accumulation of mitochondria (arrow) (vii) and 
intermyofibrillar accumulation of mitochondria (arrows) (viii), and focal Z-band 
abnormalities (arrows). 
 
The subject lost ambulation at age 10 years. Progression of scoliosis necessitated spinal 
fusion at age 11 years, and recurrent pneumonias and declining lung function resulted in 
tracheostomy and invasive ventilation at age 14 years. Since then, the patient’s clinical 
status has been stable. At last follow-up, at age 23 years, she was ventilated 20 hours per 
day, fed by a gastric tube, but was able to raise her arms against gravity. A diagnosis of 
TRAPPC11-related limb girdle muscular dystrophy 2S (LGMD2S) was made by whole 
exome sequencing (MYO-SEQ project) that revealed a homozygous variant c.2938G>A; 
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p.Gly980Arg. This variant is rare in both gnomAD and ExAC (0.007% and 0.004%, 
respectively, with no homozygotes) with a CADD PHRED score of 34.0 (Table 3.1). 
 
Subject S3 is the eldest of three children of consanguineous Syrian parents. She was born 
at term without complications. Birth weight was 3200 g, length was 50 cm, and head 
circumference was 35 cm (all values 25th – 50th centile). Her early motor development 
was delayed, and she achieved free walking at age 2.5 years. She developed a proximal 
muscle weakness with difficulties when rising from the floor after age 5 years. At age 10 
years, her walking distance was reduced to about 100 m, and since age 25 years, she is 
only able to walk a few steps. At last follow-up, at age 32 years, her condition was stable. 
She had normal GOT values, but moderately increased GPT values (maximum 186 U/l). 
Her CK was elevated up to 600-1800 U/l. In addition, amylase and lipase values were 
slightly elevated on several occasions without any clinical signs of pancreatic 
dysfunction. Her cholinesterase values were normal. Echocardiography performed 
several times during the course of disease was always normal, whereas her vital capacity 
(VC) was reduced to approximately 50%, but she has not required ventilation. An 
ophthalmological examination revealed a bilateral cataract (Figure 3.3A) (Table 3.2). A 
psychological examination at age 18 years yielded an IQ of 85, and cranial MRI at age 32 
years showed a mild cortical atrophy. A muscle biopsy taken at age 27 years showed 
muscle fibers with features of an unspecific myopathy (Figure 3.3B) and an MRI 
displayed fatty muscle degeneration (Figure 3.3C). Diagnosis of TRAPPC11-related 
LGMD2S was established by whole exome sequencing that revealed the homozygous 
variant c.2938G>A; p.Gly980Arg (Bogershausen et al., 2013). 
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Figure 3.3 Eye and muscle abnormalities in subject S3 at age 27 years. 
(A) Eye examination displays non-progressive cataracta coerulea. (B) H&E stained 
sections show muscle fibers with minor variation in diameter and few internal nuclei 
(arrows) (i). COX/SDH staining depicts some fibers with little subsarcolemnal 
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mitochondrial aggregates (arrow) (ii). No upregulation is seen when using antibodies 
against MHC neonatal in the muscle fibers (iii). Staining with antibodies against MHC 
slow shows normal distribution of type 1 or 2 fibers (iv). A few muscle fibers show 
myofibrillar disintegration with antibodies against myotilin (arrow) (v). Sarcolemmal α-
dystroglycan expression is normal (vi). Ultrastructural analysis shows that the 
sarcolemma is focally folded with moderate subsarcolemmal accumulation of 
mitochondria (arrow) (vii). The myofibrillar architecture shows focal mild alterations 
with mitochondrial aggregates and extralysosomal glycogen (arrow) (viii) and focal 
unspecific loss of z-bands (arrows). (C) T1-weighted muscle MR images of S3 at age 30 
years showing marked replacement of all pelvic muscles (gluteus maximus, iliacus, 
obturator internus, pectineus, and psoas muscles) by fat and connective tissue. At the 
upper thigh level, the vastus intermedius, the abductor magnus and brevis muscles were 
also severely affected whereas the vastus lateralis muscle was relatively spared. 
Similarly, the lower lower thigh muscles appeared well preserved. 
 
Table 3.2 Clinical features of subjects in this study with TRAPPC11 variants 








age of onset first year of life first year of life 3-4 years not reported, 
family history 
of early onset 
muscle symptoms axial hypotonia  axial hypotonia  axial hypotonia None 
motor ability unable to sit or 
stand 






muscle biopsy minimal myopathic 
changes 
Myopathic Myopathic not performed 
CK (IU/l) 350-2817 600-1800 400-1500 700-1000 
hyperkinesia Yes No No No 
spasticity Yes No No No 
choreiform 
movements 









Yes Yes Yes Moderate 
microcephaly Yes No No No 
neuroimaging cerebral atrophy 
and reduced white 
matter volume 






No No Cataract No 
hepatic 
involvement 






3.4.2 Fibroblasts from Subjects S1, S2 and S3 Have Membrane Trafficking Defects 	
TRAPPC11 was first identified as a protein that associates with the TRAPP III membrane 
trafficking complex (Scrivens et al., 2011). Depletion of the protein in HeLa cells 
resulted in Golgi fragmentation. Previous studies have suggested that some variants result 
in reduced levels of the protein (Bogershausen et al., 2013; Koehler et al., 2017; Liang et 
al., 2015), possibly leading to morphological changes in the Golgi. We found reduced 
levels of TRAPPC11 in S1 (Figure 3.4A), consistent with the unstable protein generated 
by the c.1287+5G>A allele as previously reported (subject S3.1, Figure 3.4A) 
(Bogershausen et al., 2013). In contrast, S2 and S3 had levels of the protein comparable 
to that of control (Figure 3.4A), as would be expected for a missense variant. Consistent 
with reduced TRAPPC11 levels, fibroblasts from S1 displayed severe Golgi 
morphological alterations resulting in highly fragmented Golgi membranes (Figure 3.4B, 
C). The Golgi alterations could be rescued by transfection of the cells with wild-type 
TRAPPC11 fused at either the amino- or carboxy-terminus to the biotin ligase BirA 
(Figure 3.4B, C), confirming that the Golgi morphological alterations were TRAPPC11-
dependent. The BirA served as a steric impediment for the function of these ends of the 
protein as recently shown (Stanga et al., 2019). Thus, neither the carboxy- nor amino-
terminus of TRAPPC11 is critical for its function in maintaining normal Golgi 
morphology. 
 
We then examined the fibroblasts for membrane trafficking defects using the RUSH 
assay (Boncompain et al., 2012). In this assay, a fluorescent cargo protein is retained in 
the ER until the cells are exposed to biotin. The cargo (ST-eGFP and ManII-mCherry) is 
then monitored as it exits the ER and arrives in the Golgi. As shown in Figure 3.5A and 
B, fibroblasts from all three subjects of this study as well as subject S4 displayed a delay 
in arrival of both cargo proteins at the Golgi compared to control. We then examined the 
trafficking of a marker protein (VSVG-GFP ts045) that traverses the biosynthetic 
pathway, allowing for assessment of cargo arrival and release from the Golgi (Scales et 
al., 1997). In this assay, VSVG-GFP ts045 is retained in the ER at restrictive temperature 
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(40°C) and released upon downshift to permissive temperature (32°C). In fibroblasts 
from all three subjects as well as S4, we noted a delay in arrival of the protein at the 
Golgi, consistent with the results of the RUSH assay, as well as a defect in release of the 
protein from the Golgi (Figure 3.5C). Based on these two assays we conclude that 




Figure 3.4 Golgi morphology is altered in fibroblasts from individual S1. 
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(A) Lysates were prepared from control, S1, S2 and S3 fibroblasts and probed for 
TRAPPC11 and tubulin (as a loading control). Molecular size standards are indicated to 
the right of the blots. Note that the tubulin and TRAPPC11 blots are from the same gel. 
(B) Fibroblasts from S1 were untransfected (ø), fixed and stained with antibodies 
recognizing the Golgi marker mannosidase II or transfected with a TRAPPC11 construct 
fused at the amino terminus or the carboxy terminus to the protein BirA (green) (BirA-
C11 and C11-BirA, respectively). The BirA fusions contained a FLAG epitope tag to 
allow for identification of transfected cells. Note the altered morphology of the Golgi in 
fibroblasts from the affected individual that is rescued by either TRAPPC11 construct. 
The non-merged image is shown in the lower panel with the Golgi in white. (C) 
Quantification of the images from panel (B) was performed using criteria previously 
established (Milev et al., 2017; Scrivens et al., 2009). N values ranged from 25 to 38 in a 




Figure 3.5 Trafficking from the ER to the Golgi and exit from the Golgi is delayed 
in fibroblasts from individuals S1, S2 and S3. 
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The RUSH assay was performed on fibroblasts from control, S1, S2 and S3 using ST-
eGFP (A) and mannosidase II (ManII)-mCherry (B). The cells were imaged every minute 
over a period of 20 minutes after the addition of biotin to induce release of the cargo 
molecule from the endoplasmic reticulum. Fluorescence in the Golgi region was 
quantified as described in Koehler et al (2017) (Koehler et al., 2017) and is displayed to 
the right of the representative images. (C) Fibroblasts from control, subjects S1, S2 and 
S3 were infected with virus expressing VSV-G-GFP ts045. After 1 hour, the cells were 
shifted to the restrictive temperature of 40°C overnight. Prior to imaging the cells, 
cycloheximide was added. The cells were then imaged every minute over a 2-hour period 
at 32°C. Fluorescence in the Golgi region was quantified for the N values indicated over 
at least two independent experiments as described above and is displayed to the right of 
the representative images. The scale bars represent 25 µm and the error bars represent 
SEM. 
 
3.4.3 Fibroblasts from Subjects S1, S2 and S3 Display a Defect in Protein 
Glycosylation 
 
A previous study using mainly zebrafish as a model system suggested that TRAPPC11, to 
the exclusion of other TRAPP-associated proteins, plays an undetermined role in protein 
N-glycosylation (DeRossi et al., 2016). When examined in HeLa cells, depletion of 
TRAPPC11 resulted in defective glycosylation of TRAP- α, a resident ER protein whose 
glycosylation is independent of membrane trafficking. We therefore examined the 
fibroblasts from S1, S2, S3 and S4 for the glycosylation state of TRAP-α. The inclusion 
of S4 in this and subsequent analyses allows us to assess whether the c.3379-3380InsT 
allele in subject S1 is sufficient for normal TRAPPC11 function. As shown in Figure 
3.6A, fibroblasts from all four subjects showed a form of TRAP-α that migrated between 
the fully and the unglycosylated forms of the protein in addition to a form that co-
migrated with the fully glycosylated protein. The partially glycosylated form was not 
seen in fibroblasts from an individual with bi-allelic variants in TRAPPC12 (Milev et al., 
2017), supporting our previous work in HeLa cells that indicates this is specific to defects 
in TRAPPC11 (DeRossi et al., 2016). These results demonstrate that, similar to a partial 
depletion of TRAPPC11 in HeLa cells, the TRAPPC11 variants reported herein also 
affect protein glycosylation. 
 
Glycosylation defects can result in a build-up of proteins in the ER leading to ER stress, 
which can manifest by up regulation of a set of genes including ATF6, XBP1, DDIT3, 
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BIP, DNAJC3, EDEM1 and ATF4 responsible for a particular class of the unfolded 
protein response (Vacaru et al., 2014). ER stress is also associated with proteolytic 
processing of the ATF6 transcription factor to a faster-migrating species (Haze et al., 
1999). We therefore examined fibroblasts from S1, S2, S3 and S4 for signs of ER stress 
by both qPCR and ATF6 processing. Except for XBP1 expression, which showed a 
modest increase in subject S1 of 2.70 ± 0.49 fold compared to control, no other genes 
examined showed any increase (not shown). Furthermore, ATF6 processing did not 
reveal any significant differences when compared to control (not shown). Therefore, 
unlike the zebrafish trappc11 mutant model system (DeRossi et al., 2016), we conclude 
that the bi-allelic TRAPPC11 variants reported herein result in a glycosylation defect in 
fibroblasts but do not result in an increase in expression levels of genes that are reported 




Figure 3.6 Assessment of glycosylation and autophagic flux defects in fibroblasts 
from individuals S1, S2, S3 and S4. 
(A) Lysates were prepared from fibroblasts from control, subjects S1, S2, S3 and S4 (an 
individual with a homozygous c.1287+5G>A variant (Bogershausen et al., 2013)) as well 
as an individual with a homozygous c.145delG variant in TRAPPC12 (Milev et al., 2017) 
(C12). The lysates were fractionated by SDS-PAGE, transferred to PVDF membrane and 
probed for the ER-resident glycoprotein TRAP-α. A portion of the lysate from control 
cells was treated with endoglycosidase H to convert the glycosylated (G) form of the 
protein to the unglycosylated form (uG). (B) Fibroblasts from control, subjects S1, S2, S3 
and S4 were left in nutrient rich medium (0) or starved for 1, 2 or 4 hours. One sample 
was starved for 4 hours in the presence of Bafilomycin A1 (4B). Lysates were prepared 
and probed for LC3 and tubulin as a loading control. The graph shows the ratio of the 
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autophagy-specific (LC3-II) form of the protein normalized to tubulin. In all cases, the 
tubulin blots are from the same gel as the LC3B blots. Note that samples from control 
and S2 were fractionated on the same gel, while S1, S3 and S4 were from different gels. 
Error bars indicate SEM. A representative blot from a minimum of three replicates is 
shown below the graph. (C) Fibroblasts from control, subjects S1, S2, S3 and S4 were 
left either in nutrient-rich medium or starved for 2 hours. The cells were then fixed and 
immunostained for LC3 and LAMP1. (D) Co-localization between LC3 and LAMP1 
from the cells in panel (c) was quantified using Imaris. Statistical significance was 
assesed using a one-way ANOVA with posthoc Tukey HSD analysis. The asterisk (*) 
indicates p<0.0001. (E) Fibroblasts from control, subjects S1, S3 and S4 were starved for 
2 hours in the presence of Bafilomycin A1, lysates were prepared and fractionated into 
low speed (LP), high speed (HP) pellets and a high speed supernatant (HS) fraction as 
described in the methods section. The fractions were subjected to proteinase K (ProK) 
with or without pre-treatment with the detergent Triton X-100 and then probed for LC3. 
Each sample was fractionated on a separate gel. Molecular size standards are indicated to 
the right of the blots in panels (A), (B) and (E).  
 
3.4.4 Fibroblasts from Subject S1 Display a Defect in Autophagic Flux 
 
We have recently shown that TRAPPC11 functions in an early stage of autophagy, after 
the formation of nascent isolation membranes (Stanga et al., 2019). Therefore, we 
examined the fibroblasts from all three subjects for defects in autophagic flux as 
measured by the starvation-induced accumulation and then disappearance of the 
autophagic marker LC3-II. As shown in Figure 6B, the fibroblasts from S1 and S4, but 
not S2 nor S3, displayed a defect in autophagic flux since LC3-II could not be cleared 
from the cells over the time course of starvation examined. The fibroblasts from S1 also 
displayed a high level of LC3-II even prior to starvation-induced autophagy. Although 
the accumulation of LC3-II prior to starvation was not as dramatic in S2, S3 and S4 as 
compared to S1, the levels were nevertheless elevated in the fibroblasts derived from 
these three subjects. 
 
In order to confirm the autophagic flux defect, we examined the fibroblasts for co-
localization between the autophagosome marker LC3 and the lysosome marker LAMP1. 
Co-localization would suggest that the formation of autolysosomes, organelles resulting 
from the fusion of autophagosomes with lysosomes, has taken place. Control fibroblasts 
showed a relatively high level of starvation-dependent co-localization between the 
marker proteins, as did fibroblasts from S2 and S3 (Figure 3.6C and D). Consistent with 
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the autophagic flux defect in S1, fibroblasts from this individual showed poor starvation-
dependent co-localization. The same was noted for subject S4. 
 
Using a protease protection assay (Velikkakath et al., 2012), we recently demonstrated 
that the starvation-dependent accumulation of LC3 punctae in S1 were in fact unsealed 
isolation membranes (Stanga et al., 2019). This assay works by separating lysates into 
two different membrane fractions (LP and HP) and a cytosolic fraction (HS). The 
fractions are treated with protease K either with or without detergent. If the 
autophagosomal marker LC3-II is susceptible to digestion in the absence of detergent, 
then the autophagosome membranes are not considered to be sealed. Employing this 
assay, we showed that, consistent with the autophagic flux and co-localization data 
above, fibroblasts from S3 are not defective in producing sealed autophagosomes since 
membrane-associated LC3 was only susceptible to protease digestion in the presence of 
detergent, similar to what was seen in control (Figure 3.6E). In contrast, and similar to 
fibroblasts derived from S1, fibroblasts from S4 in which full-length TRAPPC11 is 
absent also failed to seal isolation membranes into autophagosomes since LC3-II was 
susceptible to proteinase K treatment in the absence of detergent. Collectively, our data 
suggest that the extreme carboxy-terminus of TRAPPC11, but not residue Gly980, is 




It is becoming increasingly clear that proteins described as TRAPP subunits and thought 
to be stable components of a mammalian TRAPP complex, may not in fact be stably 
associated with the complex. This is in contrast to the yeast TRAPP proteins that seem to 
be stably associated with either TRAPP II or TRAPP III (Kim et al., 2006; Sacher et al., 
2001; Sacher and Ferro-Novick, 2001; Sacher et al., 1998), and only break down into the 
likely artifactual TRAPP I upon incubation in high salt (Brunet et al., 2012). The 
implication of this idea is that these TRAPP-associated proteins are capable of 
functioning independently of the complex. This is supported by the non-identical, but 
partially overlapping clinical phenotypes associated with TRAPP protein variants 
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(reviewed in (Sacher et al., 2019)). Further support comes from the fact that several 
proteins including TRAPPC2, TRAPPC9, TRAPPC11 and TRAPPC12 have been 
uniquely implicated in collagen export, NF-κB signaling, N-linked protein glycosylation 
and chromosome congression, respectively, in addition to a role in membrane trafficking 
(DeRossi et al., 2016; Hu et al., 2005; Milev et al., 2015; Venditti et al., 2012). Even 
within TRAPP III, the complex-specific proteins TRAPPC8, TRAPPC11 and 
TRAPPC12 appear to have differing functions (Stanga et al., 2019). Thus, in order to 
better understand how these proteins can function in multiple and shared cellular 
processes it is necessary to identify regions of the proteins that are critical for their 
participation in a specific process. 
 
We have described an individual with novel compound heterozygous TRAPPC11 variants 
as well as two individuals with identical homozygous p.Gly980Arg variants that allow us 
to speculate on important regions of the protein that mediate different cellular processes 
(Figure 3.7A). The severity of the muscle weakness and the course of the disease differed 
distinctly between the two subjects harboring the same homozygous mutation. Therefore, 
it appeared meaningful to analyse the pathophysiological effects of the genetic defect in 
both of them. Using fibroblasts derived from these individuals, we have implicated 
Gly980 as part of a region critical for both membrane trafficking and N-linked 
glycosylation, but not in the maintenance of normal Golgi morphology. The Gly980 
residue also does not appear to be crucial for autophagy. A multisequence alignment 
revealed that this region of the protein is highly conserved and that this residue in 
particular is invariant (Bogershausen et al., 2013). Expansion of the alignment to include 
more phylogenetically distant organisms confirms that this residue is indeed invariant 
(not shown). Although this variant was reported to likely affect protein structure, this 
may be very localized as it does not affect autophagy, a process that is believed to be 
linked to the extreme carboxy terminus (see below). 
 
Subject S1 differs clinically from S2 and S3 mainly because of the presence of spasticity, 
hyperkinesia and choreiform movements. However, these clinical signs have been 
previously reported separately or in combination in other individuals with TRAPPC11 
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variants (including the c.1287+5 G>A variant) and in individuals with variants in other 
TRAPP proteins (TRAPPC9 and TRAPPC12) as recently reviewed (Sacher et al., 2019). 
Thus, some of these clinical features may be related to the function of TRAPPC11 
proteins in their corresponding TRAPP complexes and to the expression of these proteins 
in the central nervous system. Furthermore, the impairment of autophagy observed only 
in S1 and associated with the c.3379_3380insT mutation may also contribute to the 
spasticity and choreiform movements since these clinical signs are characteristic of other 
human diseases in which autophagy plays a significant role (e.g. hereditary spastic 
paraparesis due to mutations in TECPR2 and SPASTIZIN (Jiang and Mizushima, 2014), 
and Huntington´s disease (Soares et al., 2019)). 
 
With respect to the compound heterozygous case, the variant c.1287+5G>A 
(p.Ala372_Ser429del) was previously described in homozygous form (Bogershausen et 
al., 2013; Popp et al., 2017). The resulting protein appeared to be unstable as it was not 
detected by western analysis. One study demonstrated that this variant affects membrane 
trafficking (Bogershausen et al., 2013). Here we also demonstrated that this variant 
affects formation of autophagosomes and results in an N-linked glycosylation defect. 
These results are not unexpected considering that the protein levels of this variant are 
undetectable. The compound heterozygous individual also displays defects in all three 
processes (membrane trafficking, autophagy and N-linked glycosylation) as well as in 
maintenance of normal Golgi morphology, implicating the extreme carboxy terminus of 
the protein in its functions. This is based on the fact that full-length TRAPPC11 is still 
detectable in this individual, likely reflecting the p.Asp1127Valfs*47 protein. Further 
support for the importance of the extreme carboxy terminus comes from the absence of 
this allele in both gnomAD and ExAC. A multisequence alignment limited to humans, 
rodents, canine and bovine reveals that the carboxy terminus, like the rest of TRAPPC11, 
is well conserved (Figure 3.7B). When more phylogenetically distant organisms are 
included, the conservation of this region of the protein begins to drop (Figure 3.7C). 
Thus, we speculate that higher eukaryotes may have evolved a unique autophagy-related 
function in the carboxy terminus of the protein. It remains to be seen if mutations at the 
extreme carboxy terminus of the TRAPPC11 protein in these phylogenetically distant 
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organisms will affect autophagy. Recent work from our laboratory suggests that this 
region of the protein is important for recruiting the ATG2B-WIPI4 complex (Stanga et 
al., 2019), a factor that is required for the sealing of isolation membranes into enclosed 
autophagosomes (Velikkakath et al., 2012). 
 
TRAPPC11 dysfunction has been implicated in protein N-glycosylation. The first report 
came from a study using a zebrafish trappc11 mutant which displayed reduced levels of 
lipid-linked oligosaccharides and upregulation of genes necessary for terpenoid 
biosynthesis, a precursor for the carbohydrate carrier dolichol (DeRossi et al., 2016). This 
same study was also the first to implicate human TRAPPC11 in protein N-glycosylation. 
Two recent reports have suggested that naturally-occurring TRAPPC11 variants are 
associated with defective glycosylation of the muscle protein alpha-dystroglycan (Larson 
et al., 2018) and altered glycosylation of both serum transferrin and apoCIII (Matalonga 
et al., 2017). Here, we have extended the glycosylation defect to three more TRAPPC11 
variants (subjects S1, S2/S3 and S4), suggesting that this may be a hallmark of 
TRAPPC11 dysfunction. While one variant in this study (subject S4) has reduced levels 
of the protein (Bogershausen et al., 2013), subject S1 does not show the same. Instead, 
this subject has a variant near the carboxy terminus of TRAPPC11. The affected region 
of the protein is similar to a previously published TRAPPC11 variant (p.Thr1104Ala) 
that was reported to have glycosylation defects (Matalonga et al., 2017), though 
TRAPPC11 protein levels were not reported. It is noteworthy that the latter variant also 
displayed a modest (2-2.5 fold) increase in the expression levels of four genes involved in 
the unfolded protein response (UPR), including XBP1 which was also modestly elevated 
in our study. Thus, activation of UPR may be correlated to the extent of the glycosylation 
defect, an idea that requires further study. In the three subjects reported herein, the 
glycosylation defect seen in the fibroblasts might be mild since a substantial amount of 
fully glycosylated protein is also detected in all three subjects. 
 
We considered the possibility that the carboxy-terminal extension of 46 residues might 
create an unexpected motif that could alter the function of the resulting protein. To this 
end we first scanned these residues in the Eukaryotic Linear Motif (ELM) database. As 
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expected, we identified a number of potential phosphorylation sites, kinase- and 
phosphatase-interacting motifs, and an N-linked glycosylation motif. Such motifs are not 
unexpected and none of them could help explain the membrane trafficking or autophagic 
flux defects that we reported. It should be stressed that we recently showed that only an 
amino-terminal tag on TRAPPC11, and not a carboxy-terminal tag, could rescue a 
TRAPPC11-dependent autophagy defect (Stanga et al., 2019), further highlighting the 
importance of the unblocked C-terminal end of TRAPPC11. 
 
With the identification of several new individuals harboring variants in TRAPPC11, the 
present study strengthens the relationship between dysfunction of this gene and 
pathophysiology, and implicates various regions as critical for the normal function of the 
protein. There are now five reported variants within the foie gras domain (Bogershausen 
et al., 2013; Larson et al., 2018; Liang et al., 2015; Matalonga et al., 2017; Popp et al., 
2017; Wang et al., 2018), suggesting that this domain is important for the function of the 
protein. Identification of subject S2 makes a total of three published individuals with a 
G980 variant (Bogershausen et al., 2013; Liang et al., 2015), and here we show that this 
residue is important for membrane trafficking and protein glycosylation but not for 
autophagy. Finally, the variants in subject S1 suggest an important role for the extreme 
carboxy terminus of the protein. Considering that there are two other reports of 
individuals having variants close to the carboxy terminus at residues Thr1104 (Matalonga 
et al., 2017) or Pro1005 (Wang et al., 2018), the importance of this region of the 1133 
amino acid-long protein may be extended to the final ~130 amino acids, overlapping with 
the gryzun domain. While a function for the carboxy terminus of the protein in autophagy 
has recently been elucidated (Stanga et al., 2019), how this region affects membrane 
trafficking and protein glycosylation remains to be determined in future studies. It is 
notable that these latter variants are in close proximity to the gryzun domain (Figure 
3.7A), a region of the protein whose function remains unknown. 
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Figure 3.7 Functions associated with variants in subjects S1, S2 and S3, and the 
conservation of the carboxy terminus of the protein. 
(A) Domain topology of TRAPPC11 showing the location and the variants described in 
this study. The foie gras domain (amino acids 263-521) is shaded in blue and the deletion 
resulting from the c.1287+5G>A variant is shaded in cyan. The first altered residue 
resulting from the c.3379_3380insT variant is indicated in blue and the resulting 
extension of the carboxy terminus is indicated in red. The gryzun domain is shaded in 
pink. A summary of the assay results and protein levels is indicated below the cartoon. 
For the assays, “+” indicates the assay was affected by the variant and “-“ indicates it was 
not. For the protein levels, + indicates the presence of the protein and – indicates its 
absence. (B,C) A multiple sequence alignment of the carboxy terminus of TRAPPC11 
(starting from amino acid 1081) using H.sapiens, R.norvegicus, M.musculus, B.taurus 
and C.lupus B) or the former species as well as X.tropicalis, G.galus, D.rerio, 
D.melanogaster, A.gambiae, C.elegans and A.thaliana (C). Black shading represents 
identities in at least 4 species in (B) and 9 species in (C) and gray represents similarities 
in at least 6 species in (C). The asterisks indicate the position of two TRAPPC11 variants 
that have been described in this region from the present report and in Matalonga et al 
(Matalonga et al., 2017). The lines above the sequences in panel (B) inidicate predicted 
α-helices in the human sequence using JPred4. 
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Chapter 4: Discussion  	
4.1 Overview 
 
Although evolutionarily conserved, the mammalian TRAPP III complex appears to be 
significantly different from its yeast counterpart in both structure and function. 
Structurally, it features four peripheral subunits attached to the core of the complex rather 
than one. Functionally, the mammalian complex localizes to ERES and recycling 
endosomes in addition to just the Golgi, and it participates in COP II recruitment to the 
ER in addition to common roles in autophagy and ER to Golgi transport (Lamb et al., 
2016; Scrivens et al., 2011; Zhao et al., 2017). 
 
Here, I defined the role of mammalian TRAPP III in autophagy. Interestingly, at least 
three of the four peripheral subunits act at different steps of the pathway: TRAPPC8 
participates in the formation of isolation membranes, TRAPPC11 is required to elongate 
isolation membranes, and TRAPPC12 acts downstream of TRAPPC11 after 
autophagosome formation. Based on studies in fibroblasts derived from individuals with 
mutations in TRAPPC11, I observed that the absence of, or alteration to, the carboxy-
terminus of TRAPPC11 affected the formation of autophagosomes, a phenotype 
consistent with a defect in isolation membrane elongation. I also found a delay in 
trafficking from ER to Golgi and exit from the Golgi related to TRAPPC11 variants. 
These results raise an important question concerning the mechanism of TRAPP III in the 
secretory pathway and autophagy: whether TRAPP III indeed affects both of these 
processes directly, or whether its action upon one of the processes is causing a secondary 
effect upon the other. Since there is crosstalk between membrane trafficking and 
autophagy, delays in trafficking can affect the localization and availability of important 





4.1.1 TRAPPC11 Specifically Interacts with ATG2 and Functions in the Elongation 
of the Isolation Membrane 
 
Since there could be multiple explanations for the failure to recruit ATG2 to the isolation 
membrane in either the absence of TRAPPC11 or when its carboxy terminus is altered, I 
aimed to distinguish between direct protein-protein interactions and indirect effects such 
as a defect in vesicular trafficking which might prevent the arrival of ATG2 at the 
isolation membrane. The studies in Chapter 3 helped to tease apart the causality of these 
effects influenced by alterations in the TRAPPC11 gene. Subject 1 has a compound 
heterozygous variant causing one allele to express an unstable protein, while the other 
allele includes a frame-shift mutation at the carboxy-terminus. Subjects 2 and 3 both 
harbour a homozygous missense variant causing a point mutation in a highly-conserved 
region. Subject 4 harbours a homozygous variant which leads to the absence of protein. 
Fibroblasts from these four individuals were also compared to those from subject C12, 
who has a homozygous mutation in TRAPPC12, leading to a severely truncated protein 
(Chapter 2). 
 
Consistent with previous studies showing that depletion of TRAPPC11 in HeLa resulted 
in Golgi fragmentation (Scrivens et al., 2011), both subject 4 (Bogershausen et al., 2013) 
and subject 1, with their reduced levels of protein, displayed severe Golgi fragmentation. 
Using the cargoes ST-eGFP and ManII-mCherry in the RUSH assay, all four subjects 
showed a delay in ER to Golgi traffic. Moreover, using VSVG-GFP ts045, cells from 
these subjects were delayed in the entire biosynthetic pathway. Even though all subjects 
displayed trafficking defects, subjects 1 and 4 had a blockage of autophagic flux due to 
unsealed isolation membranes while subjects 2 and 3 had an increased number of 
autophagosomes that were consumed when autophagy was induced. Similarly, cells with 
the TRAPPC12 variant also displayed defects in Golgi morphology and delays in the 
entire biosynthetic pathway (Milev et al., 2017). Nevertheless, subject C12 showed a 
blockage in autophagic flux with accumulation of autophagosomes. When the 
recruitment of ATG2 to isolation membranes was assessed, subjects 1 and 4 showed a 
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defect, unlike subjects 2, 3 and C12 which did not. This suggests that the delay in 
membrane trafficking and the defect in ATG2 recruitment are not mutually-dependent. 
 
Since disruption of vesicular trafficking can affect the recruitment of ATG2 to isolation 
membranes, one might expect that other factors in the autophagy pathway would also be 
influenced. I next examined ATG12, a member of the ATG12-ATG5 complex, which 
functions as a ubiquitin-like molecule to induce the lipidation of LC3 (Walczak and 
Martens, 2013) and therefore acts upstream of ATG2. By analyzing isolation membranes 
derived from the subjects, no difference in ATG12 levels was observed. This further 
supports the conclusion that TRAPPC11 affects autophagy directly.  
 
Another point of interplay between membrane trafficking and autophagy is at the level of 
COPII vesicles. In mammals, TRAPPC12 modulates the recruitment of Sec13/31 to the 
outer layer of COPII vesicles (Zhao et al., 2017). Additionally, COPII vesicles seem to be 
important in autophagosome biogenesis, specifically when it comes to LC3 lipidation (Ge 
et al., 2014). Since LC3 is already lipidated in the subject fibroblasts, COPII vesicles do 
not seem to have any effect on the recruitment of ATG2.  
 
Rab proteins represent yet another link between the secretory and autophagy pathways. 
For example, Rab1a was found to be important for omegasome formation (Huang et al., 
2011; Zoppino et al., 2010). Since current models assume that TRAPP III is a GEF for 
Rab1 (Li et al., 2017; Yamasaki et al., 2009), it is feasible that any change to the TRAPP 
complex could affect Rab1 activation. To validate the specific role of TRAPPC11, I 
examined whether a dominant-negative form of Rab1 could phenocopy TRAPPC11 
depletion, and whether a constitutively-active form of Rab1 could suppress that same 
phenotype. Neither was observed, suggesting that the phenotypes seen upon depletion of 
TRAPPC11 are not due to a change in Rab1 activity. Collectively, my results support the 
model of TRAPPC11 directly and specifically recruiting ATG2 to isolation membranes, 
independent of its role in membrane trafficking. 
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4.1.2 TRAPPC11 Recruits ATG2 and WIPI4 
 
ATG2 and WIPI4 form a complex that is found on the growing isolation membrane. 
Since the depletion of TRAPPC11 phenocopies depletion of either ATG2 or WIPI4, and 
since I suspect that TRAPPC11 directly interacts with ATG2, the order of recruitment 
was then probed. First, immunoblots against TRAPP proteins in cells depleted of ATG2 
or WIPI4 were performed, and then these were compared to immunoblots against either 
ATG2 or WIPI4 in cells depleted of TRAPPC8, TRAPPC11 or TRAPPC12. I observed 
that when either ATG2 or WIPI4 were depleted, TRAPP proteins were recruited onto 
membranes upon induction of autophagy. However, when TRAPPC11 was depleted, 
neither ATG2 nor WIPI4 were detected on membranes, despite the fact that the 
recruitment of ATG12-ATG5 was not affected. Consistent with its role in the initiation of 
the isolation membrane, cells depleted of TRAPPC8 did not display any sign of ATG2, 
ATG12, WIPI4, TRAPPC11 nor TRAPPC12 on membranes, likely due to the absence of 
the isolation membrane. Interestingly, TRAPPC12 depleted cells showed normal 
recruitment of ATG2, WIPI4 and ATG12-ATG5. Overall, immunoblotting results are 
consistent with TRAPP III being required for the recruitment of ATG2 and WIPI4.  
 
4.1.3 The Mechanisms of ATG2 Recruitment Differ between Mammals and Lower 
Eukaryotes 
 
If TRAPPC11 is solely responsible for the recruitment of ATG2 and WIPI4 in 
mammalian cells, this would differ from the proposed mechanism of autophagosome 
biogenesis in yeast, where the complex Atg2-Atg18 can associate with the PAS 
independently of TRAPP complexes and is held at the membrane by Atg9 (Gomez-
Sanchez et al., 2018). Additionally, Atg9 was found to recruit vesicle-tethering proteins 
Trs85 and Ypt1 to the PAS (Kakuta et al., 2012). 
 
While the mechanism of autophagosome biogenesis is highly conserved between yeast 
and mammals, the function of Atg9 seems to have diverged. In yeast, Atg9 was found to 
recruit vesicle-tethering proteins Trs85 and Ypt1 to the PAS (Kakuta et al., 2012). Atg2, 
a key protein in autophagosome biogenesis, has two membrane-binding regions with a 
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role in membrane tethering during elongation of the isolation membrane, and it also 
possesses an amphipathic helix that targets the Atg2-Atg18 complex to the PAS and 
facilitates binding between Atg18 and PI(3)P (Kotani et al., 2018). Although Atg2 and 
Atg9 can interact, it was recently proposed that Atg2 can associate with autophagosomal 
membranes through lipid binding, without the assistance of Atg9. Instead, the function of 
Atg9 is to retain the Atg2-Atg18 complex on the PAS once it has already arrived 
(Gomez-Sanchez et al., 2018).  
 
A similar but more evolved mechanism exists in mammals. Contrary to yeast cells that 
have a single PAS, mammalian cells have multiple omegasomes, which serve as 
autophagosome nucleation sites. As such, there is a potential benefit to rapid cycling of 
autophagy factors. Mediated by TRAPPC8, the mammalian TRAPP III complex interacts 
with TBC1D14 upon initiation of autophagy, allowing ATG9 vesicles to cycle from one 
omegasome through the endomembrane system to the Golgi, and from there to another 
omegasome (Lamb et al., 2016). Analogously to yeast, there is an interaction between 
ATG2 and the human Atg18 homologue WIPI4 at the nucleation site (Maeda et al., 
2019), and it is thought that ATG2 transfers lipids between membranes, mediating de 
novo autophagosome biogenesis (Ktistakis, 2019; Osawa et al., 2019b; Osawa and Noda, 
2019; Valverde et al., 2019). However, ATG9 is not involved in this process. Human 
ATG9 does not interact with ATG2B, nor with WIPI4 (Chapter 2), and a review of the 
literature did not uncover any known interactions between ATG9 and either isoform of 
ATG2, nor with WIPI4. 
 
Why might mammalian cells need to employ a different mechanism of ATG2 recruitment 
to isolation membranes than that of lower eukaryotes? Yeast Atg9 recruits TRAPP III, 
Ypt1 and Atg2-Atg18 to promote the elongation of the isolation membrane, whereas 
mammalian ATG9 seems to have a transient role in the recruitment of TRAPP III and 
Rab1 through interaction with TBC1D14. ATG2-WIPI4 recruitment is still required, but 
it is mediated by TRAPPC11 and not ATG9. To contextualise this difference, I offer two 
speculative ideas. First, since there are multiple sites for autophagosome nucleation in 
mammalian cells, cycling ATG9 between the Golgi and these sites in a processive 
		 104	
fashion could be the most efficient way to provide important cues for autophagosome 
biogenesis simultaneously at multiple sites. Second, considering that mammalian TRAPP 
III is bulkier than the yeast complex, it is possible that the presence of TRAPP III on the 
mammalian isolation membrane somehow hinders ATG9 and renders it ineffective as an 
ATG2 interactor, thereby necessitating the involvement of TRAPPC11 as a specialized 
intermediary.  
 
4.1.4 TRAPPC11 Also Functions Independently of the TRAPP III Complex in the 
N-glycosylation Pathway 
 
Both in the autophagy pathway, where it interacts with ATG2, as well as in the secretory 
pathway, the functions ascribed to TRAPPC11 are dependent upon its membership in the 
TRAPP III complex. However, TRAPPC11 was also found to function independently of 
the complex and regulate N-glycosylation through the formation of lipid-linked 
oligosaccharides (DeRossi et al., 2016). I examined N-glycosylation in HeLa cells by 
observing the mobility of the ER-localized signal sequence receptor TRAPα (Wu et al., 
2007). TRAPα has two glycosylation sites whose glycans are not processed in the Golgi, 
making it an ideal marker to identify site occupancy defects. Aberrant glycosylation of 
TRAPα was seen only after depletion of TRAPPC11, while depletion of either 
TRAPPC2, TRAPPC8 or TRAPPC12 did not affect the glycosylation process (DeRossi 
et al., 2016). This suggests that TRAPPC11 is the only TRAPP protein involved in N-
glycosylation. 
 
To confirm the involvement of TRAPPC11 is complex-glycosylation, I then assessed the 
level of glycosylation of TRAPα in fibroblasts from the aforementioned individuals with 
variants in TRAPPC11 (subjects 1-4) and compared them to subject C12. I observed 
defects in glycosylation of TRAPα in subjects 1, 2, 3 and 4, but not in subject C12. In 
order to further validate the specificity of TRAPPC11 in glycosylation, I also analyzed 
TRAPα in fibroblasts harbouring a variant in TRAPPC4. This variant results in vastly 
reduced TRAPPC4 levels, resulting unstable TRAPP complexes in these cells (Van 
Bergen et al., 2019). I found no difference compared to the control cells, which supports 
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the previous finding that TRAPPC11 acts in N-glycosylation independent of the TRAPP 
III complex (DeRossi et al., 2016).  
 
Taken together, I propose that TRAPPC11 has an unidentified moonlighting function in 
protein glycosylation (DeRossi et al., 2016). This is not the first TRAPP subunit proposed 
to have a moonlighting function, as TRAPPC12 dissociates from the complex upon 
phosphorylation to regulate kinetochore stability and CENP-E recruitment (Milev et al., 





TRAPPC11 functions in at least three intracellular pathways: glycosylation, vesicular 
trafficking, and autophagy. Its role in N-glycosylation is distinct from other TRAPP 
proteins, and without its function in lipid-linked oligosaccharide synthesis, 
hypoglycosylated proteins accumulate. However, TRAPPC11 is unable to act in ER to 
Golgi traffic alone, rather it is incorporated into the TRAPP III complex where it is a 
critical factor. Apart from its function in membrane traffic, TRAPPC11 also affects 
autophagy as a TRAPP III subunit, through direct interaction with the ATG2-WIPI4 
complex. Individuals having variants in different TRAPP subunits harbour a wide range 
of different phenotypes, although overlap is observed. In the case of TRAPPC11, there 
are an increased number of reports of individuals with neuromuscular disorders and 
intellectual disabilities (Bogershausen et al., 2013; Fee et al., 2017; Koehler et al., 2017; 
Larson et al., 2018; Liang et al., 2015; Matalonga et al., 2017). 
 
The crosstalk between membrane trafficking and glycosylation is well documented. 
Following synthesis in the ER, glycosylated proteins are transported through the Golgi en 
route to their final destination, subject to covalent attachment and modification of glycans 
along the way. The glycosylation process relies heavily upon the compartmentalization of 
glycosylation enzymes. Any disturbance of the finely regulated balance between 
anterograde and retrograde trafficking could potentially lead to abnormal glycans that 
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cause premature degradation, mislocalization, improper retention, loss of Golgi stability 
and/or global trafficking delays. As such, TRAPPC11 is not the only protein involved in 
both membrane traffic and glycosylation. It is well documented that the COG complex is 
essential in intra-Golgi trafficking due to its ability to coordinate Rab GTPases, golgins, 
coat proteins and SNAREs during vesicle tethering (Climer et al., 2015; Sohda et al., 
2010). Studies performed on individuals with congenital disorders of glycosylation 
revealed the importance of the COG complex in Golgi-based glycosylation, due to its role 
in recycling vesicles that contain glycosyl-transferases (Reynders et al., 2011; Shestakova 
et al., 2006). The pathologies observed in these individuals showcase the inherent link 
between trafficking deficiencies and an altered glycosylation pattern (Foulquier et al., 
2007; Foulquier et al., 2006; Morava et al., 2007; Zeevaert et al., 2008). 
 
Just as membrane trafficking and glycosylation are interdependent, changes to either of 
them can also influence autophagy. The organelles most notably affected are lysosomes, 
which are responsible for degrading extracellular and intracellular material delivered by 
either endocytosis or autophagy, respectively (Saftig and Klumperman, 2009). The 
components designated for degradation pass across a thick lysosomal membrane to reach 
an acidic compartment containing more than fifty hydrolases. To create a barrier between 
the acidic luminal milieu and the cytosol, membrane proteins in the lysosome are heavily 
glycosylated (Fukuda, 1991). The most abundant lysosomal associated membrane 
proteins, LAMP‐1 and LAMP‐2, have more than ten glycosylation sites. As one might 
expect, defects in the glycosylation of these proteins can trigger their retention in the ER 
and subsequent degradation by ERAD, which results in a deficiency of membrane 
proteins in lysosomes. This deficiency affects not just the lysosomal pH but also the 
entire physiology of the lysosome, as some hydrolases are inactive at less-acidic pH 
levels. To date, more than twelve different disorders have been linked to a lack of 
lysosomal membrane proteins. For example, Danon disease, caused by the absence of 
LAMP-2, is characterized by severe skeletal and cardiac myopathies and an increased 
number of autophagosomes in myocytes (Nishino et al., 2000). These same symptoms are 
also observed in individuals who have variants in TRAPPC11 (Bogershausen et al., 2013; 
Fee et al., 2017; Liang et al., 2015). 
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NPC1 is an example of a disease in which trafficking is affected by mutations to genes 
encoding the Niemann-Pick type C protein, leading to a subsequent defect in autophagy. 
The variant proteins impair amphisome formation and autophagosome maturation (Sarkar 
et al., 2013). This produces hepatic dysfunction, ataxia, spasticity and dementia. Some of 
the individuals with variants in TRAPPC11 also have disorders including liver fibrosis 
and fatty liver (Fee et al., 2017; Liang et al., 2015). However, some of the individuals 
with variant TRAPPC11 proteins also display neurodevelopmental phenotypes, which are 
not associated with neither Danon nor with NPC1. There is a potential link between 
neuronal disorders and autophagy if reduced autophagic degradation and/or dysregulated 
autophagy causes abnormal protein aggregates (Nah et al., 2015). 
 
In summary, membrane trafficking is critically important to autophagy and glycosylation, 
among other pathways. In order to define a precise role of human TRAPP proteins in 
cellular physiology, one must begin by accounting for the interplay between these 
processes. The mechanisms underpinning the plethora of phenotypes observed across 
individuals with TRAPPC11 variants are key to understanding not only the functional 
roles of this protein, but also to developing new insights into the causes of other 
neuromuscular diseases. TRAPPC11 serves in trafficking as part of TRAPP III, promotes 
elongation of the isolation membrane by direct recruitment of ATG2, and moonlights in 
the synthesis of lipid-linked oligosaccharides. The burgeoning field of glycomics can 
further elucidate the mechanism of the N-glycosylation role, which will perhaps explain 
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